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Bacteria thrive in many different habitats, and therefore will encounter a 
multitude of environmental stresses. Survival requires the development of 
sophisticated response mechanisms that can identify potential threats and initiate 
regulatory cascades orchestrating the expression of defensive components.  
The cell envelope is the first layer of the cell to come in contact with any 
environmental agent. In Gram-positive bacteria this envelope is comprised of a 
cytoplasmic membrane surrounded by a thick multilayered cell wall. The cytoplasmic 
membrane forms an essential permeability barrier and is made of different types of 
complex lipids which vary not only in the length and modifications of the acylated 
fatty acid groups but also in the composition of their headgroups. The cell wall is a 
complex matrix consisting predominantly of equal amounts of peptidoglycan and 
teichoic acids with the addition of surface attached proteins. Cell wall synthesis and 
maturation requires both incorporation of new peptidoglycan by penicillin-binding 
proteins, as well as cleavage of the existing peptidoglycan by autolysins.  
The work presented here describes the use of external stimuli or genetic 
manipulations to elucidate cell envelope stress responses. First, I have identified a 
possible novel post-translational modifier of autolysin activity, which is induced by 
cell wall-targeting antibiotics. This modifier is proposed to inhibit autolytic enzyme 
activity under conditions of impaired cell wall synthesis, thereby reducing the rate of 
antibiotic-dependent cell death. Second, I studied a transcriptional regulator 
controlling the expression of efflux pumps proposed to be involved in resistance to 
cell-wall targeting antibiotics. Finally, by genetic perturbation I created a series of B. 
subtilis strains with altered cytoplasmic membrane composition, and characterized 
them for growth, antibiotic resistance, morphology, and alterations in global gene 
expression patterns. B. subtilis retains viability and even rapid growth when the 
membrane is comprised predominantly, if not exclusively, of one type of complex 
lipid, suggesting that the cell can tolerate even large changes in membrane 
composition.  
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CHAPTER ONE 
 
The Cell Envelope of the Gram-positive Bacillus subtilis 
 
The cell envelope of Bacillus subtilis and other Gram-positive organisms is comprised 
of a cytoplasmic membrane surrounded by a thick multilayered cell wall. Unlike 
Gram-negative bacteria, which possess an additional outer membrane, the Gram-
positive cell wall serves as a surface organelle, the first layer of the cell to come in 
contact with any environmental agent. The following chapter outlines the structure and 
biosynthesis of the Bacillus subtilis cell envelope as well as outlining how the cell 
detects stress signals.  
1. The Cell Wall 
The cell wall of Gram-positive bacteria forms a rigid structure that defines the 
cell-shape and provides protection against mechanical and osmotic pressures (20,51). 
The cell wall is a complex matrix consisting predominantly of equal amounts of 
peptidoglycan (PG) and teichoic acids (TA) (4), with the addition of surface attached 
proteins. 
1.1 Peptidoglycan synthesis and assembly 
PG is comprised of chains of the alternating disaccharides N-
acetylglucosamine (NAG) and N-acetylmuramic (NAM) acid. These chains are 
crossed-linked to neighboring chains by short stem peptides attached to the NAM (63), 
thereby providing increased tensile strength. 
The synthesis of PG is shown in Figure 1.1. Briefly,  the PG precursors UDP-
NAG and UDP-NAM, and the subsequent linking of the pentapeptide chain (5P) 
containing a terminal D-Ala-D-Ala to UDP-NAM take place in the cytoplasm (51). 
Then the UDP-NAM-5P is linked to an undecaprenyl- pyrophosphate carrier 
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Figure 1.1. Cell wall biosynthesis and its inhibition by antibiotics. Important steps in 
cell wall biosynthesis are schematically depicted, and their cellular location is 
indicated below. GlcNAc, N-acetylglucosamine; MurNAc, N-acetylmuramic acid. 
Amino acids are symbolized by grey circles. Cell wall antibiotics mentioned in this 
chapter are indicated next to the steps they inhibit. Antibiotics in green sequester the 
substrate of the given step; those in red inhibit the corresponding enzymatic function. 
Adapted from Jordan et al. (32) 
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molecule (C55-PP) forming Lipid I followed by the addition of UDP-NAG to NAM 
resulting in Lipid II (Fig. 1.1) (51). Lipid II is then translocated across the membrane 
to the site of peptidoglycan polymerization where it is incorporated into the growing 
glycan chain (24). This last step is catalyzed by penicillin binding proteins (PBPs), 
which can be divided into two main categories: high molecular mass (HMM) PBPs, 
and low molecular mass (LMM) PBPs (63). Polymerization of the glycan chains 
(transglycosylation; TG) and insertion into the pre-existing cell wall is carried out by 
HMM-PBPs (63). HMM-PBPs contain a C-terminal domain where the 
transpeptidation (TP) activity responsible for peptide cross-linking between two 
adjacent glycan chains is located (63).  These PBPs can be further divided into either 
class A or class B based on the structure of their N-terminal domain (63, 24). In the 
case of class A HMM-PBPs this domain is responsible for the elongation of the glycan 
chains (TG). The LMM-PBPs can be divided mainly into carboxypeptidases or 
endopeptidases, that target the peptide chain (7) thus affecting the degree of cross-
linking in the cell wall (51). 
 The classical “inside-to-outside” model for peptidoglycan assembly proposes 
that new wall material is inserted at the inner face of the wall, adjacent to where the 
PBPs are located (64). As new layers of PG are added, the wall moves outward and 
the outer layers become more stressed, leading to greater autolytic activity (64). Thus 
newly closed layers of cell wall are formed prior to degradation of older outer layers 
(64). This paradigm has been challenged by recent findings using fluorescently labeled 
antibiotics that target different steps in peptidoglycan synthesis. Studies imaging 
peptidoglycan biosynthesis with fluorescent ramoplanin and vancomycin revealed 
helical patterns along the cylindrical wall of cells (71). In addition, nascent 
peptidoglycan incorporation was found to be dependent on the presence of helical 
filaments of Mbl, the bacterial actin homolog (18). These findings have given rise to a 
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model for the helical assembly of the cell wall, predicting a non-random and spatially 
restricted mechanism of nascent peptidoglycan incorporation into the cell wall (4).  
1.2 Peptidoglycan degradation 
Autolysins are bacteriolytic enzymes that degrade the peptidoglycan of the 
bacteria that produce them (68). These enzymes have been proposed to play a role in 
many cellular processes including cell growth, cell-wall turnover, peptidoglycan 
maturation, cell division, motility, chemotaxis, competence, protein secretion, 
sporulation and pathogenicity (7,39, 68). 
Left unchecked, autolysins will degrade the cell wall leading to its rupture and 
eventually to cell death. Therefore, fine-tuning of autolysin activity through efficient 
and strict regulation is crucial for bacterial survival. Autolysin activity and expression 
are controlled on a number of levels. Hypothetical mechanisms for post-translational 
regulation of autolysin activity include: proton motive force (36), secreted proteases 
(70), or the binding of positively charged autolysins to anionic polymers in the cell 
wall (28). Transcriptional control is often orchestrated by complex interdependent 
regulatory machinery, including a set of alternative sigma factors, thus ensuring that 
the autolysins are expressed specifically during the growth stage at which their activity 
is required (68). 
  Amino acid similarity searches of the Bacillus subtilis genome identified 35 
genes coding for candidate peptidoglycan hydrolases (68). These autolysins are 
classified according to the peptidoglycan bond they target: muramidases, 
glucosaminidases, N-acetylmuramoyl-L-alanine amidases (amidase) and 
endopeptidases (68; Fig 1.2).  
During vegetative growth, B. subtilis produces two major autolysins, a 50 kDa 
N-acetylmuramoyl-L-alanine amidase encoded by lytC and a 90 kDa endo-β-N-
acetylglucosaminidase encoded by lytD, which together account for ~95% of the cells 
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autolytic activity (68). These autolysins play roles in several cellular functions 
including: cell wall turnover during vegetative growth by dissolving the outermost 
murein layer (37), separation of cells after septation by splitting the newly constructed 
septum (37), cell lysis induced by the addition of cell-wall-synthesis-inhibiting 
antibiotics (7), as well as facilitating motility by separating linked cells, and enabling 
release of mature endospores by lysis of the mother cell at the end of sporulation (68). 
These two major autolysins along with the γ-D-glutamate-meso-
diaminopimelate muropeptidase, LytF (42) are under the transcriptional control of the 
alternative sigma factor σD. σD is active in late exponential phase and is involved in 
the regulation of several cellular functions including flagellar synthesis, motility, 
chemotaxis and expression of autolysins (43). Additionally, the extracytoplasmic-
function (ECF) sigma factor σX (12) and the YvrGH two-component system (TCS) 
(66) are also potentially involved in the transcriptional regulation of autolysins. 
1.3 Teichoic acid structure and function 
 Teichoic acids (TA) are highly charged anionic polymers (20). In B. subtilis 
this polymer is comprised of repeating units (45-60) of glycerol phosphate, and its 
biosynthetic machinery is encoded by the tag genes (tagABDEFGHO) (5).  TAs can 
be divided into wall teichoic acids (WTA) and lipoteichoic acids (LTA). WTAs are 
covalently bound to NAM residues in the cell wall via a linkage unit comprised of two 
glycerol phosphate residues linked to N-acetylmannosaminyl-N-acetylglucosaminyl-
phosphate (24). LTAs are linked to the cytoplasmic membrane via a glycolipid anchor 
(24), synthesized by the diglucosyldiacylglycerol synthase, UgtP (52, 38).  
The sugar residues of TAs can be further modified by esterification with D-
alanine. Modification with D-Ala reduces the net charge of the cell envelope by 
incorporation of free amino groups (NH3+) (58). The dltABCDE operon responsible  
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Figure 1.2.  Schematic example of bonds hydrolyzed by the different classes of 
autolysins: (1) Glucosaminidase, (2) Muramidase, (3) Amidase, (4) Endopeptidase. 
Adapted from Smith et al. (68) 
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 for D-alanine esterification of  both WTA and LTA in B. subtilis, has been shown to 
be transcriptionally controlled by extracytoplasmic function sigma factor, σX (12). 
D-Ala modified TAs have been proposed to be involved in various functions 
related to their anionic nature: modulation of autolysin activity, maintaining cation 
homeostasis, assimilation of metal cations for cellular function, and defining the 
electrochemical properties of the cell wall (52). 
Although TAs are considered essential for cell viability, when phosphate levels 
are limited, the tag operon is repressed and the tua operon, which encodes the 
enzymes involved in the teichuronic acid, is induced (10). Teichuronic acids (TUA) 
contain the anionic glucuronic acid but are phosphate free; therefore they can satisfy 
the need for an anionic polymer while freeing up phosphate (5). 
In addition, recent findings (20) have shown that deletion of the gene encoding 
for the first biosynthetic step (tagO) results in a viable mutant, albeit demonstrating 
slow growth and altered colony morphology. This suggests that while teichoic acids 
play a crucial role in maintaining the shape of B.subtilis cells, they are not essential for 
viability.   
1.4 Cell-wall targeting antibiotics 
 Due to the great importance of the cell wall in providing protection against 
mechanical and osmotic pressures, it serves as a target for many antibiotics, which can 
affect different steps in its biosynthetic pathway. Below are detailed the modes of 
action of some of the better studied cell-wall targeting antibiotics.  
Fosfomycin is a simple three-carbon epoxy propyl phosphonate produced from 
phosphoenolpyruvate (PEP) by Streptomyces wemorensis (67, 74).  Fosfomycin acts 
as a PEP analog, and irreversibly inhibits the first step of peptidoglycan synthesis, 
catalyzed by MurA, by covalently binding to its active site (67, 74).  
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D-cycloserine inhibits the interconversion of the commonly found L-Ala to D-Ala, by 
acting as a suicide inhibitor of the alanine racemase (23), as well as inhibiting the D-
Ala- D-Ala ligase which incorporates this component into the pentapeptide chain (74). 
Ramoplanin is a lipoglycopeptide antibiotic which inhibits the activity of bacterial 
transglycosylases by binding to Lipid II found at the external surface of the membrane 
(29). 
Bacitracin, a nonribosomal decapeptide antibiotic, binds to and prevents the recycling 
of the C55-PP lipid carrier thus inhibiting cell wall synthesis (49). 
Cephalosporin is a member of the β-lactam family of antibiotics, which block 
transpeptidation of the glycan chains. β-lactams serve as suicide substrates for PBPs, 
which mistake them for a yet to be cross-linked PG chain (74). 
Vancomycin, a glycopeptide antibiotic binds specifically to the D-Ala- D-Ala terminus 
of the pentapeptide chain, thus inhibiting both transpeptidation and transglycosylation 
activities by blocking access of the enzymes to their substrate (34).  
Common resistance mechanisms for these antibiotics include efflux of the 
antibiotic via pumps (48,56), expression of enzymes that inactivate the antibiotic (11, 
26), or modification of the target molecule. This latter mechanism is exemplified by 
vancomycin resistant Enterococci (VRE) that contain enzymes that can replace the D-
Ala- D-Ala terminus with a D-Ala- D-lactate terminus which will not be recognized by 
vancomycin (34). 
 
2. The cytoplasmic membrane 
The cytoplasmic membrane forms an essential permeability barrier and is a 
defining feature of life. In most bacteria, the membrane is a lipid bilayer composed of 
fatty esters linked to sn-glycerol-3-phosphate (G3P) (59). These complex lipids vary 
not only in the length and modifications of the acylated fatty acid groups but also in 
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the composition of their headgroups, which differ significantly in charge and 
propensity to form non-bilayer structures within the membrane. The membrane of the 
soil bacterium Bacillus subtilis is a complex structure comprised mainly of the anionic 
phospholipid phosphatidylglycerol (PhG) and the zwitterionic 
phosphatidylethanolamine (PhE). Other components include a relatively large amount 
(~30%) of neutral glycolipids (GL), a variable amount of positively charged 
lysylphosphatidylglycerol (LPG), and a small amount of anionic cardiolipin (CL) (Fig 
1.3).  
The complex composition of the membrane is presumed to be important since 
the physical properties of membrane lipids influence many cell processes including 
division (55), DNA replication (30), and protein transport (16). For example, the 
anionic lipids PhG and CL mediate the cycling of the DNA replication protein DnaA 
from the ADP-DnaA to ATP-DnaA (active) state, and inhibit the binding of DnaA to 
oriC via sequestration (8). E. coli cells with reduced amounts of anionic phospholipids 
accumulate outer membrane proteins in the cytoplasm and some proteins insert 
incorrectly into the membrane (72). Furthermore, CL and PhE facilitate the formation 
of non-bilayer structures (16) important in cell division and sporulation (47). 
Interestingly, the functional requirement for specific lipid characteristics does not 
restrict membrane composition, and bacteria exhibit great diversity not only in the 
content of their lipid head groups, but also in their relative abundance within the 
membrane (Table 1.1). This diversity represents an adaptation to environmental 
conditions. For example, in oligotrophic marine environments phospholipids can be 
replaced by sulfolipids (73; Table 1.1).  
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Figure 1.3. Pathways for membrane lipid synthesis in B. subtilis.  Membrane lipid 
synthesis begins with the common precursor phosphatidic acid (PA) and leads to the 
generation of glycolipids (GL), phosphatidylglycerol (PhG), 
phosphatidylethanolamine (PhE), cardiolipin (CL), and lysylphoshatidylglycerol 
(LPG). Key enzymes and substrates are indicated and steps blocked by mutation are 
denoted with an “X” (see chapter four).  Note that in the absence of UgtP, LTA is still 
synthesized but the glycerol-phosphate copolymer is linked to the membrane by 
diacylglycerol (DAG) rather than by diglucosyl-DAG.  
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Recent evidence suggests that these various lipid species may assort into 
spatially distinct lipid micro-domains (69), which in turn may affect the localization of 
membrane proteins (47). In B. subtilis CL-rich and PhE-rich domains are localized to 
the septal regions and the poles (35, 54), corresponding with the FtsZ-dependent 
subcellular localization of the lipid biosynthesis enzymes PssA, YwnE, and PgsA 
(phosphatidylglycerophosphate synthase; 54).  
In B. subtilis, membrane lipids are synthesized from the common precursor 
phosphatidic acid (PA; Fig 1.3). In the case of PhE, PA is converted to CDP-
diacylglycerol (CDP-DAG) which is condensed with serine and then rapidly 
decarboxylated to generate PhE. Condensation of CDP-DAG with glycerol-3-
phosphate followed by removal of the phosphate leads to PhG, the only essential 
complex lipid in B. subtilis. PhG can be further modified to form two minor complex 
lipids CL and LPG. CL is formed by the condensation of two PhG molecules by 
cardiolipin synthase (CLS). B. subtilis contains two CLS enzymes: the major form 
(YwnE; also called ClsA (35)) is expressed during vegetative growth, while the minor 
(YwjE) is involved in sporulation (35). LPG is formed when MprF transfers a lysyl 
group from lysyl-tRNALys to PhG. Finally, GL are created by dephosphorylation of 
PA to diacylglycerol which is then modified by the transfer of one or two glucose 
molecules from UDP-glucose by UgtP (31). Fatty acid synthesis and desaturation are 
controlled by the FapR (65), and DesRK (17) regulatory systems and both chain 
length and desaturation may be regulated by various stress conditions  (41, 50, 40, 61). 
In contrast, little is known about how membrane headgroup composition is regulated, 
although the extracytoplasmic-function (ECF) σ factor σX has been shown to 
contribute to expression of PhE biosynthesis genes (12).  
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 3. Cell envelope stress response in Bacillus subtilis 
Bacteria thrive in many different habitats, and therefore will encounter a 
multitude of environmental stresses. Survival requires the development of 
sophisticated response mechanisms that can identify potential threats and initiate 
regulatory cascades orchestrating the expression of defensive components. 
Components of the cell envelope are often involved in these response mechanisms, 
since the cell-envelope serves as a first line of defense against environmental 
challenges. 
In B. subtilis, control of gene expression patterns in response to external stress 
signals is coordinated by a suite of alternative sigma factors and two-component 
regulatory systems both containing a transmembrane sensory component (Fig 1.4).  
3.1 Extracytoplasmic-function (ECF) σ factors  
ECF σ factors often control functions associated with cell surface, transport or 
secretion. A typical ECF σ factor is cotranscribed with a downstream regulatory gene, 
or anti-σ factor. This anti-σ factor is usually located in the cytoplasmic membrane and 
negatively regulates the activity of the σ factor by binding it directly (27). When an 
extracytoplasmic stress signal is sensed, the ECF σ factor is released, binds to core 
RNA polymerase (RNAP), and directs transcription initiation from specific promoter 
sites (27).  ECF σ factors often regulate their own transcription (autoregulation) and 
that of their anti-σ factor, therefore determination of the upstream promoter sequence 
can be used to help identify other genes with similar regulatory elements. 
B. subtilis possesses seven ECF σ factors, σX, σW, σM, σY, σV, σZ and σylaC 
identified based on sequence similarity (27). The function of these σ factors has been 
studied through a combination of genetic, biochemical and bioinformatics tools. 
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Figure 1.4. Regulatory principles orchestrating cell envelope stress response in Gram-
positive bacteria. On the left, ECF σ factors, and on the right, two-component systems 
(HK, histidine kinase; RR, response regulator). Sensor proteins are shown in green, 
inhibitor in blue, transcriptional regulators in red. Arrows indicate activation, T-
shaped lines repression. CM, cytoplasmic membrane. Adapted from Jordan et al. (32) 
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To date, the best understood of these σ factors are σX, σW and σM which control genes 
involved in cell envelope synthesis and / or modification (27).  
σX, the first ECF σ factor to be sequenced in B. subtilis (27), and its cognate 
anti-σ-factor are encoded for by a bi-cistronic operon (sigXrsiX). The σX regulon was 
defined using promoter consensus search and in vitro runoff transcription-macroarray 
analysis (ROMA) (12). σX was found regulate transcription of the dltABCDE operon, 
responsible for D-alanine esterification of TAs, and to partially control the 
transcription of the pssAybfMpsd operon responsible for the biosynthesis of PhE (12). 
In addition, sigX mutants demonstrate increased sensitivity to cationic antimicrobial 
peptides (CAMPs), and an increased rate of autolysis (12). Based on these findings it 
was concluded that σX regulates resistance to CAMPs via modification of cell surface 
properties (12). 
Τhe σW regulon, comprised of 30 operons (~60 genes), was identified using 
promoter consensus search, ROMA and transcriptional profiling approaches (13). The 
σW regulon is induced by alkali shock (75), vancomycin (14), and the mammalian 
cationic peptide LL37 (60), but does not seem to confer resistance to these stresses 
(14, 60). However, σW was found to control the transcription of a major fosfomycin 
resistance determinant (11). In addition, using a panel of B. subtilis mutants disrupted 
for each of the 30 operons it was discovered that genes in the σW regulon provide 
intrinsic resistance to antimicrobial compounds produced by Bacilli species, thus 
enabling B. subtilis to maintain its niche in the face of other antibiotic-producing 
bacteria (9).  
Α comprehensive study of the σM regulon was conducted using promoter 
consensus search, ROMA and transcriptional profiling approaches and σM was found 
to affect the transcription of genes involved in cell wall biosynthesis, shape 
determination and cell division, DNA damage responses and detoxification enzymes 
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(21). A subset of these genes are indirectly regulated by σM via induction of Spx (21), 
which can act both as both a positive and negative transcriptional regulator (76).  
An interesting topic arising from these studies is the overlap in transcriptional 
regulation between σM and other ECF σ factors (21). This overlap further complicates 
the precise definition of regulons, as well as the elucidation of in vivo regulatory 
networks. 
3.2 Two-Component regulatory Systems (TCS) 
 TCS are comprised of a membrane bound sensor histidine kinase (HK) and a 
cytoplasmic response regulator (RR). An external stress signal is sensed by the HK, 
causing the kinase to autophosphorylate a histidine residue. The phosphoryl group is 
then transferred to an aspartic acid residue on the RR, thus activating it (22). 
 Transcriptional profiling in response to treatment with CAMPs (60) and cell 
wall targeting antibiotics (45) have revealed differential expression patterns for a 
number of TCS. Treatment with bacitracin resulted in the induction of three TCS: 
LiaRS, BceRS and YvcPQ (45). The HK of these systems are classified as intra-
membrane sensing HK, and are proposed to sense stimuli either directly inside or at 
the surface of the cytoplasmic membrane (44). 
BceRS represents a large group of TCS associated with an ATP-binding 
cassette (ABC) transporter. The genes encoding for the ABC transporter are usually 
organized in a separate operon, the expression of which is completely dependent on 
the associated TCS (44). BceRS regulates the expression of the BceAB ABC 
transporter, which is the major bacitracin resistance determinant in B. subtilis (2). 
The LiaRS TCS is actually a representative of a three-component system. The 
LiaRS TCS is linked to a third protein LiaF, which inhibits LiaR-dependent 
transcription (33). In addition to bacitracin, LiaRS is induced by other antibiotics 
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which interfere with the cycling of lipid II such as ramoplanin or vancomycin and the 
CAMP LL37 (46). 
Although not directly induced by antibiotics, the YycFG essential TCS has 
been implicated in cell wall homeostasis (Fig 1.5). YycFG was found to activate the 
expression of autolysins, and repress the expression of an autolysin activity modulator, 
and that of a peptidoglycan deacetylase (the activity of which affects susceptibility to 
lysozyme; 6) In addition, the YycG HK was found to localize to the division septum, 
and its effective kinase activity requires the presence of the division septum (25).  This 
data supports a model according to which the YycFG TCS coordinates cell growth and 
division with external events such as cell wall restructuring (25). 
 
The bacterial cell envelope is an essential component determining cell shape, 
and providing protection against mechanical and osmotic pressure. The cell envelope 
also serves as a first line of defense against external stress, and therefore the ability to 
sense and respond to the presence of challenges to the envelope is crucial for the cell’s 
survival. 
The overall goal of the work presented in this dissertation is to elucidate cell 
envelope stress responses in the model Gram-positive bacteria B. subtilis, in particular 
those induced by treatment with antibiotics. The strategy for studying these responses 
was to stress cells either by the use of external stimuli or by genetic manipulation.  
Chapter two characterizes a novel post-translational modifier of autolysin 
activity, YoeB, that is under the transcriptional regulation of the YycFG essential 
TCS. This modifier is induced by cell wall-targeting antibiotics and is proposed to 
inhibit autolytic enzyme activity under conditions of impaired cell wall synthesis, 
thereby reducing the rate of antibiotic-dependent cell death (Fig 1.5).  
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Figure 1.5. Model for the role of YycFG in coordinating cell division with cell 
wall homeostasis. YycG is activated upon localization to the septum in dividing 
cells. This activation increases phosphorylation of YycF and subsequently leads 
to increased expression of autolysins and other genes involved in cell division, 
and repression of genes involved in inhibiting cell wall remodeling (yoeB and 
yjeA). In the absence of septa in non-dividing cells, YycG fails to localize, adopts 
a state of low activity, and hence YycF remains unphosphorylated. Under these 
conditions, cell wall remodeling is not required and the expression balance is 
tipped towards the genes involved in autolysin inhibitory process. Adapted from 
Fukushima et al. (25). 
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Chapter three describes a transcriptional regulator induced in response to 
glycopeptide antibiotics. The regulon of this regulator includes efflux pumps proposed 
to be involved in resistance to cell-wall targeting antibiotics. 
Finally, chapter four characterizes a series of B. subtilis strains with genetically 
altered membrane composition. Mutant strains were characterized for growth, 
antibiotic resistance, morphology, and alterations in global gene expression patterns. 
The results suggest that the cell can tolerate even large changes in membrane 
composition. 
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CHAPTER TWO 
An antibiotic-inducible cell wall-associated protein that protects  
Bacillus subtilis from autolysis* 
 
1. Summary 
In Bacillus subtilis, antibiotics that impair cell wall synthesis induce a 
characteristic stress response including the σW and σM regulons and the previously 
uncharacterized yoeB gene. Here, I demonstrate that YoeB is a cell wall-associated 
protein with weak sequence similarity to a non-catalytic domain of Class B penicillin-
binding proteins. A null mutant of yoeB exhibits an increased rate of autolysis in 
response to cell wall targeting antibiotics or nutrient depletion. This phenotype does 
not appear to be correlated with gross alterations in peptidoglycan structure or levels 
of autolysins. Promoter dissection experiments define a minimal region necessary for 
antibiotic-mediated induction of yoeB, and this region is highly conserved preceding 
yoeB homologs in close relatives of B. subtilis. These results support a model in which 
induction of YoeB in response to cell envelope stress decreases the activity of 
autolysins and thereby reduces the rate of antibiotic-dependent cell death. 
 
 
 
 
* Letal I. Salzberg and John D. Helmann (2007). J Bacteriol 189(13): 4671-4680 
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2. Introduction 
The bacterial cell wall defines cell morphology and provides it with the 
structural rigidity required to withstand osmotic pressure. In Gram positive bacteria 
the scaffold of the cell wall is comprised of a thick layer of peptidoglycan (PG), a 
polymer of alternating N-acetylglucosamine and N-acetylmuramic acid glycan chains 
crosslinked by peptide side chains (37). PG synthesis requires the transfer of the 
nucleotide sugar-linked precursors across the membrane where they are incorporated 
into the growing cell wall by penicillin-binding proteins (PBPs) (37). PBPs 
polymerize the glycan strands by transglycosylation, and catalyze cross-linking of the 
glycan chains by transpeptidation (37). 
Insertion of new material into the cell wall also requires cleavage of the 
existing PG. It has been proposed that the PBPs form complexes with the enzymes 
responsible for cleavage, the peptidoglycan hydrolases (5). These enzymes, also 
known as autolysins, have been proposed to play a role in many cellular processes 
including cell growth and division, cell-wall turnover, peptidoglycan maturation, 
motility, chemotaxis, competence, protein secretion, sporulation, and pathogenicity (2, 
23, 40).  Obstruction of cell-wall synthesis has been proposed to lead to an imbalance 
between synthesis (PBPs) and wall turnover (autolysins) and thereby lead to cell 
rupture (19). Indeed, autolysin deficient mutants of B. subtilis have increased 
resistance to D-cycloserine and β-lactam antibiotics (36). Left unchecked, autolysins 
will degrade the cell wall leading to its rupture and eventually to cell death. Therefore, 
fine-tuning of autolysin activity through efficient and strict regulation is crucial for 
bacterial survival.  
In Bacillus subtilis, autolysins are transcriptionally regulated by several 
alternative σ factors and two component systems (TCS). Transcription of the major 
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vegetative autolysins LytC and LytD is under the control of alternative sigma factor 
σD (20, 25), which is also involved in the regulation of flagellar synthesis, motility, 
and chemotaxis (26). Transcription of lytC is also under the negative control of the 
YvrGHb TCS (39). The essential YycFG TCS has been implicated in the regulation of 
two genes encoding potential autolysins, yocH and ykvT (15).  
The post-translational control of autolysins is more complicated. Dissipation of 
the proton-motive force (PMF) across the B. subtilis membrane leads to rapid lysis of 
the cells (17). It has also been reported that the cell wall of B. subtilis is protonated 
during respiratory growth causing acidification of the local environment of the 
autolysins (6). The low pH in the cell wall may prevent the activity of the autolysins, 
and only when the enzymes are exposed to a higher pH would they become active 
(18). Indeed, it has been suggested that the bacteriolytic effect of some β-lactams is 
caused by a depolarization of the membrane potential and the consequent activation of 
autolysins (33).  
 We have investigated the transcriptional responses of B. subtilis to treatment 
with cell wall active antibiotics (7, 27). Vancomycin led to the rapid induction (3 min.) 
of ~100 genes, including the regulons controlled by the extracytoplasmic function 
(ECF) σ factors, σW and σM (7). However, one of the most strongly induced genes was 
yoeB, which is not under control of either of these ECF σ factors. A subsequent 
comprehensive study of the transcriptional responses of B. subtilis to 37 antibacterial 
compounds revealed induction of yoeB by cell wall- and membrane-targeting 
antibiotics such as cycloserine, oxacillin, vancomycin, fosfomycin, ristocetin, and 
triclosan (16). 
I here demonstrate that YoeB is a cell wall-associated protein that moderates 
the activity of autolysins. A yoeB null mutant displayed an increased rate of autolysis 
in response to various cell envelope stress conditions, but not when autolysis was 
 33
induced by dissipation of the proton motive force. Thus, YoeB functions as a 
component of a cell envelope stress response that inhibits autolytic enzyme activity 
under conditions of impaired cell wall synthesis.  
 
3. Materials and Methods 
Bacterial strains and growth conditions. All B. subtilis strains used were derivatives 
of CU1065 (W168 trpC2 attSPβ) (Table 2.1). Escherichia coli strain DH5α was used 
for standard cloning procedures. Bacteria were grown in Luria-Bertani (LB) medium, 
Difco sporulation medium (DSM) or modified Spizizen minimal medium (SMM) 
without citrate supplemented with 0.5 % glycerol (w/v), 0.02 % casamino acids (w/v) 
and 50 μg/ml of tryptophan for auxotrophic requirements (17) at 37oC with vigorous 
shaking. Antibiotics were added to the growth medium when appropriate: 100 μg/ml 
ampicillin for E. coli, and 1 μg/ml erythromycin plus 25 μg/ml lincomycin (MLS, 
macrolide-lincomycin-streptogramin B resistance), 10 μg/ml chloramphenicol and 8 
μg/ml neomycin for B. subtilis. OD600 readings were taken on a Spectronic 21 (Milton 
Roy) spectrophotometer. 
 Sensitivity to cell wall targeting antibiotics and sodium azide was measured by 
growing strains in LB medium at 37oC with vigorous shaking. Antibiotics were added 
at the indicated concentration during early exponential growth (OD600 ~ 0.25). Lysis 
was monitored by measuring the decrease of OD600 at 30 min intervals. For D-
cycloserine-treated cells, direct colony counts were performed at 0, 45, and 90 min. 
after antibiotic addition and compared to the corresponding OD600 measurements. 
Susceptibility to lysozyme was measured by resuspending 1 ml of early logarithmic 
(OD600 ~ 0.3) cell culture in 1 ml of 10 mM Tris-HCl (pH 8.0). Lysozyme was added 
at a final concentration of 2 μg/ml. The resuspended cells were incubated at 37oC 
without shaking and lysis was monitored by the decrease in OD450. 
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Construction of the yoeB null mutant. A chromosomal deletion was created using 
long-flanking homology PCR (LFH-PCR) as described (27) with the following 
changes: flanking fragments were amplified using Pfu DNA Polymerase (Stratagene) 
and the flanking fragments and antibiotic resistance gene were joined using Expand 
Long Template PCR System (Roche). Primers #1589 & #2002 were used to amplify 
the upstream fragment, and primers #2087 and #2088 were used to amplify the 
downstream fragment. Detailed protocols are available upon request. 
Overproduction of YoeB in B. subtilis with a xylose-inducible system. The yoeB 
open reading frame was PCR amplified using primers #2004 and #2005. The resulting 
PCR fragment was digested with EcoRI and HindIII and cloned into pXT, a derivative 
of pDG1731 that places the cloned gene under the control of a xylose-inducible 
promoter (PxylA) (9), creating plasmid pLS20. The sequence of the insert was verified 
by DNA sequencing (Cornell DNA sequencing facility). B. subtilis CU1065 and 
HB5345 (yoeB::MLS) were transformed to Spcr with ScaI-linearized pLS20 which 
integrates into the thrC locus. The resulting strains were designated HB5364 
(CU1065, with PxylA-yoeB at the thrC locus) and HB5365 (HB5345, with PxylA-yoeB at 
the thrC locus). 
Construction and analysis of PyoeB transcriptional fusions. DNA fragments of the 
yoeB regulatory region were PCR amplified using primers: #1713 #1714 (-514), 
#2133 #1714  (-68), #2132 #1714 (-42), #1995 #1714 (-22), #1713 #2404 (+18). The 
fragments were digested with HindIII and BamHI, and cloned into vector pDG1661, 
containing a promoterless lacZ gene (12), resulting in plasmids pLS08, pLS13, pLS14, 
pLS15 and pLS16, respectively. The sequences of the inserts were verified by DNA 
sequencing (Cornell DNA sequencing facility). B. subtilis CU1065 was transformed to 
Cmr with the ScaI-linearized plasmids which integrated into the amyE locus, creating 
strains HB5377, HB5372, HB5371, HB5370 and HB5366, respectively.  
 35
 For quantitative measurements of β-galactosidase activity, strain HB5377 was 
grown in either LB or DSM medium at 37oC with vigorous shaking, and samples were 
collected at different growth stages as determined by OD600. To test promoter 
induction, strain HB5377 was grown in LB until an OD600 ~ 0.1, and then the culture 
was split into aliquots, which were challenged with either vancomycin (2.5 μg/ml), D-
cycloserine (100 μg/ml), oxacillin (2.5 μg/ml), fosfomycin (50 μg/ml), triclosan (1 
μg/ml), monensin (0.125 μg/ml), nigericin (0.008 μg/ml), polymyxin (64 μg/ml), 
tetracycline (0.5 μg/ml), diamide (1 mM final), paraquat (100 mM final), or arsenate 
(10 μM final). To test the activity of the different length promoters strains HB5377, 
HB5372, HB5371, HB5370 and HB5366 were grown in LB until an OD600 ~ 0.1, the 
cultures were split into aliquots and challenged with vancomycin (2 μg/ml). The 
cultures were returned to 37oC, and samples were collected after 30 min. β-
galactosidase activity was measured according to the method of Miller (28) except that 
cells were lysed by the addition of lysozyme to a final concentration of 20 μg/ml 
followed by a 30 min incubation at 37oC. 
RNA isolation and slot blot hybridization. Strains CU1065, HB5377, HB5372, and 
HB5366 were inoculated into LB and grown at 37oC with vigorous shaking until an 
OD600 ~0.3, at which time the culture was split into 10 ml aliquots. To test induction 
of yoeB with various stress conditions (Fig. 2.5A), cells were challenged for 10 min at 
37oC with either vancomycin (2 μg/ml final), diamide (1 mM final), paraquat (100 
mM final), arsenate (10 μM final), triclosan (1 μg/ml), nigericin (0.008 μg/ml), 
monensin (0.125 μg/ml), or tetracycline (0.5 μg/ml). For activity measurements of 
strains containing different length promoter fusions (Fig. 2.6C) the cultures were split 
into two 10 ml aliquots, one of which was challenged with diamide (1 mM final) for 
10 min at 37oC. RNA isolation and quantification was performed as described 
previously (30). RNA samples were loaded onto Zeta-Probe Blotting Membrane (Bio-
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Rad). Signals from samples containing 2 and 0.2 μg are presented in Fig 2.5A; the 
signal from a blot with 0.8-μg loaded per lane was used to generate Fig. 2.6C. DNA 
probes were constructed by PCR. The yoeB probe was amplified using primers #2006 
and #2007 with Pfu DNA Polymerase (Stratagene) and the lacZ probe was amplified 
using primers #2640 and #2641 with Thermo-Start Master Mix (ABgene), as per the 
manufacturers’ specifications. The probes were purified with a QIAquick PCR 
Purification Kit (Qiagen), labeled with [α-32P]ATP using  DECAprime II Random-
primed DNA labeling kit (Ambion), and unincorporated [α-32P]ATP was removed by 
using NucAway Spin columns (Ambion). Slot blot hybridizations were performed 
overnight at 42oC using the NorthernMax Hybridization Kit (Ambion) according to 
the manufacturer’s instructions. Low stringency washes were performed at room 
temperature and high stringency washes at 42oC. The membranes were imaged on a 
Storm 840 PhosphorImage scanner (Molecular Dynamics) after overnight exposure of 
a PhosphorImage screen. The resulting signals were quantified using ImageQuant data 
analysis software. 
Construction and analysis of FLAG-tagged YoeB. Primers #1713 and #2430 were 
used to PCR amplify (Pfu DNA Polymerase) a 1093 bp fragment, containing the entire 
promoter region and ORF except for the terminal stop codon. The fragment was 
digested using HindIII and EagI and cloned into plasmid pJL070 (21) creating plasmid 
pLS22 containing yoeB-FLAG under control of its native promoter. pJL070 is a 
derivative of pDG1730 (12) which contains perR-FLAG cloned into the HindIII and 
EcoRI sites. pJL070 was digested with HindIII and EagI, which leaves the FLAG tag 
undisturbed. The digested plasmid was then gel purified prior to ligation. The 
sequence of yoeB-FLAG was verified by DNA sequencing (Cornell DNA sequencing 
facility). Strain CU1065 was transformed to Spcr with ScaI-linearized  pLS22, which 
integrates into the amyE locus, creating strain HB5384. To determine YoeB 
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localization, strain HB5384 was inoculated into 2 x 50 ml LB and grown at 37oC with 
vigorous shaking until OD600~ 1.0, at which point 2 x 50 ml were centrifuged for 10 
min at 4,500 x g after which one of the 50 ml pellets was resuspended in 1 ml Buffer 
A (100 mM Tris-HCl pH8.0, 1 mM MgCl2, 0.1 mM PMSF) and then sonicated 
(Crude). The second 50 ml pellet was resuspended in 1 ml of iron-starvation minimal 
medium (4) supplemented with 0.2 mM PO4, 40 mM MnCl2 and 1 mM FeSO4 (MMa) 
and centrifuged for 2 min at 5,900 x g. The pellet was then resuspended in 1 ml of 
MMb (1 x Bacillus salts (4), 40 mM MOPS (pH 7.4) and 2% glucose (w/v)) and 
centrifuged for 2 min at 5,900 x g. The pellet was then resuspended in 1 ml of MMa 
with the addition of 20% sucrose and 1 mg/ml lysozyme and incubated with agitation 
at 37oC for 40 min. Formation of protoplasts was verified by microscopy, which were 
then centrifuged for 4 min at 4,600 x g at 4oC. The supernatant was removed for use as 
cell wall fraction. The protoplasts were resuspended in 1 ml Buffer A, briefly 
sonicated and then ultracentrifuged at 45,000 rpm for 30 min (TLA 100.3 fixed angle 
rotor for Beckman TL-100 ultracentrifuge) to separate the membrane and cytoplasmic 
fractions. The membrane fraction was resuspended in 1 ml Buffer A. Cell crude 
extract, cell wall, membrane, and cytoplasmic preparations were mixed with sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) loading buffer, and 
boiled for 10 min prior to being resolved by SDS-PAGE (12% gel). After 
electrophoresis, proteins were blotted to a PVDF membrane (Bio-Rad), and YoeB-
FLAG was detected by Western-blot analysis using polyclonal anti-FLAG antibody 
from rabbit and anti-rabbit antibody conjugated to alkaline phosphatase (Sigma 
Chemical Co., St. Louis, MO.).   
Preparation of purified cell wall substrates. A 50 ml CU1065 culture was grown in 
LB to late exponential stage (OD600 = 0.6). Cells were spun down at 4,500 x g for 10 
min at 4oC, and the pellet was resuspended in 1 ml cold H2O. The suspension was 
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added slowly to 15 ml of boiling 4% SDS and boiled for 20 min. Cell wall material 
was washed three times in 1 ml ddH2O, and finally resuspended in 1 ml sterile ddH2O. 
Zymogram renaturing gel electrophoresis. Zymograms were performed as 
previously described (11). Fractionated samples were run on a 12% SDS-
polyacrylamide gel containing 4% of the peptidoglycan extract. Following 
eletrophoresis at 20mA (constant current) the gel was washed in 250 ml dH2O at room 
temperature for 30 min with agitation. The gel was then transferred to 250 ml of 
renaturation solution (0.1% Triton-X-100, 10 mM MgCl2, 25 mM Tris-HCl (pH 7.5)) 
and soaked for 30 min at room temperature with agitation. The gel was transferred to 
250 ml renaturation solution and soaked for 16 h at 37oC with agitation. The gel was 
then stained for 3 h in 100 ml of 0.1% Methylene blue, 0.01% KOH (at 37oC with 
agitation), and then destained in dH2O. Autolysin activity appeared as zones of 
clearing on a blue background. 
Succinate dehydrogenase activity assay. A 50 μl aliquot of each subcellular fraction 
was added to 950 μl of a reagent mixture containing 25 mM 2-hydroxyethylpiperazine 
(HEPES), 25 mM sodium succinate, 100 μg/ml Brij 58, 30 μg/ml 3(4,5-
dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) and 300 μg/ml 
phenazine methosulfate (PMS). Succinate dehydrogenase activity was measured at 
570 nm and units of nmol MTT reduced/min/mg protein were calculated using an 
extinction coefficient of 17,000 M-1cm-1 for reduced MTT (43). 
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Table 2.1.  Strains, plasmids and oligonucleotides used in this study 
 
 
 Description Created / 
reference 
E.coli   
DH5α φ80lacZΔm15 recA1 endA1 gyrA96 thi-1 hsdR17 (rK-, mK+) supE44 relA1 Lab strain 
    deoR Δ(lacZYA-argF)U169  
B. subtilis   
CU1065 W168 trpC2 attSPβ Lab strain 
HB5345 CU1065 yoeB::MLS LFH-PCR 
→ CU1065 
HB5364 CU1065  thrC::PxylA-yoeB pLS20 → 
CU1065 
HB5365 CU1065 yoeB::MLS thrC::PxylA-yoeB pLS20 → 
HB5345 
HB5366 CU1065 amyE::PyoeB-lacZ (+18) pLS16 → 
CU1065 
HB5370 CU1065 amyE::PyoeB-lacZ (-22) pLS15 → 
CU1065 
HB5371 CU1065 amyE::PyoeB-lacZ (-42) pLS14 → 
CU1065 
HB5372 CU1065 amyE::PyoeB-lacZ (-68) pLS13 → 
CU1065 
HB5377 CU1065 amyE::PyoeB-lacZ (-514) pLS08 → 
CU1065 
HB5384 CU1065 amyE::yoeB-FLAG pLS22 → 
CU1065 
   
Plasmids   
pXT Cloning vector for overexpression (9) 
pDG1661 Vector for integration of lacZ fusions at amyE locus (12) 
pLS08 PyoeB-lacZ (-514) in pDG1661 This work 
pLS13 PyoeB-lacZ (-68) in pDG1661 This work 
pLS14 PyoeB-lacZ (-42) in pDG1661 This work 
pLS15 PyoeB-lacZ (-22) in pDG1661 This work 
pLS16 PyoeB-lacZ (+18) in pDG1661 This work 
pLS20 yoeB cloned into pXT This work 
pLS22 yoeB-FLAG in pDG1730 This work 
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Table 2.1.  (Continued) 
 
 
   
Oligos   
#1589 GCAGCAGGAGAACCAGCAGTTCC  
#1713 CCGTAAGCTTGTCCTATCAG  
#1714 GCAGGATCCGCTCATGGTGTTCC  
#1995 CCCAAGCTTCCGTAATTATTGTAACATTTGTAAC  
#2002 GAGGGTTGCCAGAGTTAAAGGATCTCATTATCGCTCTCTCCTTC  
#2004 CCCAAGCTTTTGTAACATAAGAGAAAGAGAT  
#2005 CGGAATTCTTCACAAAAAGACAACAGGC  
#2006 GTTGGCATTATCCGCTAGAG  
#2007 CTTTCCGTTTTGCAGAAGGG  
#2087 CGATTATGTCTTTTGCGCAGTCGGCACTGTCCCTACATTAGACGG  
#2088 GCATATTGTAGAGCCGATTCGC  
#2132 CCCAAGCTTGCAAAAGTATTGTAATCTATCCG  
#2133 CCCAAGCTTGAGTAAAAGAATAAAAAATAATTTATGC  
#2404 GCGGATCCATCTCTTTCTCTTATGTTACAAATG  
#2430 CTGCACGGCCGTATAACTGCGTCAAATTGATTG  
#2640 ACAGTACGCGTAGTGCAACC  
#2641 CGCCACTTCAACATCAACGG  
Restriction sites are underlined 
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4. Results 
The yoeB mutant demonstrates an increased rate of lysis in response to cell wall 
antibiotics. A yoeB null mutant was constructed by allelic replacement with an MLS 
resistance gene using LFH-PCR (42). This mutant did not demonstrate any growth 
defects in the media tested (LB, LB+ 2% glucose, DSM), nor did it exhibit any 
changes in cellular morphology as observed by phase contrast microscopy (data not 
shown).  
I next tested the sensitivity of the yoeB mutant to different cell wall antibiotics. 
Upon exposure of logarithmically growing cells to a variety of PG synthesis inhibitors 
(vancomycin, bacitracin, cephalosporin, D-cycloserine and fosfomycin) the yoeB 
mutant exhibited an increased rate of lysis relative to wild-type (Fig. 2.1A-E). This 
increased rate of lysis is still observed when antibiotics were added at later logarithmic 
stages (OD600 = 0.4, 0.6), but not once cells entered transition stage (OD600 = ~0.8) 
(data not shown). Despite this increased rate of lysis, there was no apparent difference 
in sensitivity (<2-fold) as judged by minimal-inhibitory-concentration (MIC) assays or 
by measuring zones of growth inhibition on solid media (data not shown). Indeed, 
both wild-type and mutant demonstrated a comparable extent of lysis after prolonged 
exposure (Fig. 2.1A-E).   
To determine if YoeB protects cells against antibiotic-mediated killing, in 
addition to its obvious effects on rates of lysis, viable counts (CFU) were determined 
for D-cycloserine treated cultures of the wild-type and yoeB mutant strains. In both 
cases, a significant decrease in CFU was noted 45 min. after antibiotic treatment (~ 3-
4-fold decrease for the wild-type and ~10-fold for the yoeB mutant) despite the fact 
that the OD600 had not yet begun to decrease. After 90 min of treatment, there was a 
~5-fold drop in OD600 for the yoeB mutant and the CFU had decreased to ~2% of the 
starting value. In contrast, the wild-type cells displayed little net drop in OD600 at this 
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Figure 2.1. The yoeB mutant demonstrates an increased rate of lysis in response to cell 
wall antibiotics. B. subtilis wild-type (filled symbols) and an isogenic yoeB mutant 
(open symbols) grown in LB were either untreated (triangles) or treated at OD600 ~ 
0.25 (squares) with:  A, vancomycin (1 μg/ml); B, cephalosporin C (20 μg/ml);  
C, fosfomycin (50 μg/ml); D, bacitracin (250 μg/ml); E, D-cycloserine (100 μg/ml).  
(F) The increased rate of lysis is dependent on the absence of yoeB. Complementation 
experiments with WT and yoeB mutant strains containing Pxyl-yoeB. Filled symbols, 
WT cultures; open symbols, yoeB mutant strain. Cells were grown in LB (triangles), 
LB + 1% xylose (diamonds), LB and then treated with D-cycloserine (squares) or LB 
+ 1% xylose and then treated with D-cycloserine (100 μg/ml) (circles). The arrows 
indicate the time at which antibiotics were added. Results are representative of three 
independent experiments. 
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time (see. Fig. 2.1E) and retained 13-17% of the starting CFU. These results suggest 
that although death may precede lysis, the presence of YoeB significantly decreases 
the rate of both events. Thus, YoeB likely protects cells in environments where cell 
wall active compounds are present at low (sub-lethal) levels or exposure is transient.  
Expression of yoeB under the control of a xylose-inducible promoter 
complemented the phenotype of a yoeB null mutant and restored the slower rate of 
lysis characteristic of wild-type cells (Fig. 2.1F). To determine whether 
overexpression of YoeB could confer resistance to cell wall antibiotics, I tested lysis 
rates in wild-type cells containing a second, inducible copy of yoeB under Pxyl control. 
Overexpression did not result in decreased lysis when cells were treated with cell wall-
targeting antibiotics, suggesting that wild-type levels of YoeB are sufficient for the 
maximal protective effect.  
The yoeB mutant demonstrates an increased susceptibility to lysis upon nutrient 
depletion.  To determine if there is an innate difference in autolysis in the yoeB 
mutant strain I examined the effects of autolysis as a consequence of nutrient 
depletion. When grown in modified Spizizen’s minimal medium (17) supplemented 
with 5% glycerol, WT and yoeB mutant demonstrated comparable growth rates. 
However, once exponential growth ceased the yoeB mutant began to lyse (Fig. 2.2A) 
suggesting that it is susceptible to autolysis caused by de-energization of the cell upon 
nutrient depletion. Similar results were observed when cells grown in LB were 
resuspended in buffer (data not shown). This is consistent with the hypothesis that the 
gradual de-energization of the yoeB mutant cells leads to an imbalance in the synthesis 
and degradation of PG. In principle, the increased autolysis of the yoeB mutant could 
be due to alterations in either the substrate (PG) or effectors (autolysins) responsible 
for cell lysis.  
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Figure 2.2. The yoeB mutant demonstrates an increased susceptibility to lysis in de-
energized cells, but not in response to rapid dissipation of the proton motive force.   
(A) Cells were grown in a modified Spizizen’s minimal medium supplemented with 5 
% glycerol. WT (filled squares), yoeB mutant (open squares). Results are 
representative of three independent experiments. (B) B. subtilis WT (filled symbols) 
and yoeB mutant (open symbols) grown in LB were either untreated (triangles) or 
were treated with 0.05M sodium azide (added at OD600 ~ 0.25, indicated by arrow) 
(squares). 
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YoeB is a cell wall-associated protein.  YoeB encodes an ~19 kD protein containing 
a predicted signal sequence. To monitor localization of YoeB, I expressed a FLAG 
epitope-tagged allele of yoeB under regulation of its native promoter. The FLAG-
tagged YoeB protein was at least partially functional as judged by complementation of 
the autolysis phenotype of the yoeB null mutant. YoeB-FLAG was found in highest 
abundance in the cell wall fraction, with lesser amounts detected in the membrane 
fraction, as judged by immunoblot analysis (Fig 2.3A). The portion detected in the 
membrane fraction may correspond to cross-contamination with cell wall-associated 
proteins as judged by the fractionation of a known wall-associated protein (autolysin) 
by zymogram analysis (Fig. 2.3B). As expected, a known membrane-associated 
enzyme, succinate dehydrogenase, was found primarily (~85%) in the membrane 
fraction. Together, these results suggest that YoeB is a wall-associated protein. Semi-
quantitative analysis of the YoeB-FLAG signal intensity, by comparison with a 
dilution series of a purified FLAG-tagged protein (data not shown), suggests that 
YoeB is present in ~50-100 molecules per cell at OD600 ~1.  
Increased susceptibility to autolysis is not correlated with altered peptidoglycan.  
I hypothesized that YoeB might affect PG structure and thereby reduce the 
susceptibility of the cell to autolysis. Precedent for such effects derives from studies of 
PG deacetylases, cell wall-associated proteins that modulate the susceptibility of the 
cell to lysozyme treatment (3, 35, 41). Indeed, intact cells of the yoeB mutant are more 
sensitive to lysozyme-triggered cell lysis than wild-type (Fig. 2.4B). However, 
interpretation of this result is complex, since in these buffer conditions the yoeB 
mutant undergoes significant autolysis even in the absence of lysozyme (Fig. 2.4A).  
 To more directly test the possible effects of YoeB on PG structure, cell walls 
were purified from WT and yoeB mutant cells and tested for their susceptibility to 
degradation by lysozyme and mutanolysin. Both the rate and extent of hydrolysis 
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Figure 2.3. Localization of YoeB. (A) Western blot analysis using anti-FLAG 
antiserum. Subcellular fractions were obtained from cells containing an ectopically 
integrated FLAG-tagged copy of yoeB under regulation of its native promoter.  
(B) Zymogram assay for subcellular protein fractions. (C) Succinate dehydrogenase 
activity of subcellular fractions. Results are representative of at least three independent 
experiments. 
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were indistinguishable (data not shown). Similarly, when I used native B. subtilis 
autolysins (extracted from cells with LiCl) to digest PG from WT and yoeB mutant 
cells, there were no apparent differences. Finally, HPLC analysis of muropeptides 
prepared from vegetative WT and yoeB mutant cells demonstrated overall similar 
structural parameters: there were no significant changes in either the fraction of 
crosslinking, or the pattern or amount of sugar modifications (D. Popham, personal 
communication). These results suggest that the yoeB mutant phenotype cannot be 
obviously linked to alterations to the PG.  
Increased susceptibility to autolysis is not correlated with differences in the level 
of autolysins.  I hypothesized that YoeB might affect the levels of autolytic enzymes 
associated with the cell wall. To test this hypothesis we treated cells with sodium 
azide, a metabolic poison that rapidly dissipates the proton motive force leading to 
strong activation of autolytic enzymes. Under these conditions, the rates of lysis of 
WT and yoeB mutant cells were indistinguishable (Fig. 2.2B). This suggests that the 
autolytic potential of the cells is very similar. Further, zymogram analysis of the major 
autolytic activities present in the cell wall fractions from WT and yoeB mutant cells 
did not reveal any apparent differences in either the number or intensity of bands (data 
not shown). This technique, however, only detects the four or five most abundant 
autolysins that efficiently renature after SDS-PAGE. Finally, I note that the ability of 
the extracted autolysins from WT and yoeB mutant cells to degrade PG (from either 
WT or yoeB cells) was indistinguishable.  
 I reasoned that the yoeB mutant strain might be altered in the abundance of a 
minor autolysin or a cell wall protein not detected by zymography. However, 
comparison of the extracellular proteome of WT and yoeB mutant cells by 2D-PAGE 
also failed to reveal any obvious differences (H. Antelmann, personal 
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Figure 2.4. The yoeB mutant demonstrates an increased susceptibility for autolysis 
independent of treatment with lysozyme. Early log-phase (OD600 ~0.3) cultures of 
both wild-type and the yoeB mutants were resuspended in 10mM Tris-HCl (pH 8.0), 
without addition of lysozyme (A); or, with addition of 2μg/ml lysozyme (B). Lysis 
was monitored by a drop in OD450. Wild-type (filled squares) and yoeB mutant (open 
squares). 
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communication). In summary, these results suggest that the complement of autolysins 
is not detectably altered in the yoeB mutant strain. 
 Together, these results suggest that neither the chemical composition or cross-
linking of the PG nor the composition or potential activity of autolysins are grossly 
affected by YoeB. Therefore, I am led to a model in which YoeB functions at the post-
translational level as an inhibitor of one or more autolysins. This inhibition is 
apparently ineffective under conditions of sodium azide treatment (leading to strong 
activation of autolytic activity) or when autolysins are fractioned by SDS-PAGE and 
analyzed by zymography, but is clearly of biological relevance.   
yoeB is induced by cell-envelope targeting antibiotics. Previous transcriptome 
analyses have demonstrated that yoeB is strongly induced by vancomycin (7) and 
several other cell wall- and membrane-targeting antibiotics such as cycloserine, 
oxacillin, fosfomycin, ristocetin, and triclosan (16) (summarized in Table 2.2). Using a 
combination of β-galactosidase and slot blot analyses, I have confirmed induction of 
yoeB under many of these stress conditions. Treatment with the cell wall biosynthesis 
inhibitors vancomycin, D-cycloserine, oxacillin, and fosfomycin resulted in a ~3-4 
fold induction of the PyoeB-lacZ reporter fusion (Fig. 2.5B) and vancomycin induction 
was also observed using slot-blot analysis (Fig. 2.5A). The highest level of induction 
was obtained by treatment with triclosan (~7 fold; Fig. 2.5B), while treatment with the 
membrane-active compounds nigericin and monensin resulted in lower levels of 
induction (~2 fold; Fig. 2.5B), consistent with the induction levels noted in a previous 
transcriptome study (16) (Table 2.2). Although generally considered to be a specific 
inhibitor of fatty acid biosynthesis, triclosan also acts non-specifically as a membrane-
active compound (10, 13). Using slot blot analyses (Fig. 2.5A), I was also able to 
confirm induction of yoeB by diamide (2 fold) and the protein biosynthesis inhibitor 
tetracycline (~2 fold), although I could not detect induction using β-galactosidase 
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Table 2.2. Reported induction of yoeB under various stress conditions 
Treatment Fold change* Reference 
Cell wall biosynthesis 
  
Vancomycin  
     (2 µg/ml) 
     (0.5 µg/ml) 
 
19 (10 min)  
7.7 (40 min) 
 
(7) 
(16) 
Cycloserine (16 μg/ml) 15 (40 min) (16) 
Oxacillin (0.25 μg/ml) 7 (40 min) (16) 
Ristocetin (0.5 μg/ml) 7.8 (40 min) (16) 
Fosfomycin (256 μg/ml) 10 (80 min) (16) 
Membrane active compunds 
  
Monensin (0.125 μg/ml) 59 (40 min) (16) 
Polymyxin B (64 μg/ml) 4.9 (40 min) (16) 
Nigericin (0.008 μg/ml) 3.8 (40 min) (16) 
LL-37 9.1 (20 min) (34) 
Fatty acid biosynthesis 
  
Triclosan (1 μg/ml) 31 (10 min) (16) 
Cerulenin (4 μg/ml) 8.6 (10 min) (16) 
Protein biosnythesis 
  
Tetracycline (0.5 μg/ml) 5.1 (40 min) (16) 
Oxidants   
Diamide (1 mM) 65 (50 min) (22) 
Paraquat (100 μM)  13 (10 min) (31) 
Arsenate (10 μM ) ~65 (3 min) (29) 
* In all cases the fold change noted is the highest for the conditions tested. 
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Figure 2.5. yoeB is induced by cell-envelope targeting antibiotics. Induction of PyoeB 
compared to untreated control cells (Con) by Van (vancomycin 2.5 μg/ml), D-cyc (D-
cycloserine 100 μg/ml), Ox (oxacillin 2.5 μg/ml), Fos (fosfomycin 50 μg/ml), Tri 
(triclosan 1 μg/ml), Mon (monensin 0.125 μg/ml), Nig (nigericin 0.008 μg/ml), Poly 
(polymyxin 64 μg/ml), Tet (tetracycline 0.5 μg/ml), DA (diamide 1 mM), PQ 
(paraquat 100 mM), and As (arsenate 10 μM) was measured using (A) RNA slot blot 
analyses and (B) β-galactosidase assays. RNA slot blot results are representative of 
three independent experiments. Normalized induction ratios (NIR) were derived using 
the signal measured for the 23S probe.  β-galactosidase results are the average (± SD) 
of at least four independent cultures.  (C) Growth phase regulation of PyoeB-lacZ 
(measured using a -514 promoter fusion; see Fig. 2.6A) was monitored in either LB 
(squares) or DSM (triangles). Growth was determined by absorbance at 600 nm (filled 
symbols, axis on right) and β-galactosidase activity was measured as Miller units 
(open symbols, axis on left). Results shown are representative of three independent 
experiments. 
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assays (Fig. 2.5B). In some cases, the induction observed in DNA microarray studies 
was not reproducible under our conditions. For example, I was unable to confirm the 
observed yoeB induction by paraquat (31) or arsenate (29) (Fig. 2.5A and 2.5B). The 
lack of induction by paraquat or arsenate (Fig. 2.5B) was confirmed at the mRNA 
level (Fig. 2.5A).  
Many of the enzymes involved in cell wall biosynthesis and turnover are 
regulated during growth transitions. To examine the dependence of yoeB expression 
on growth phase, cells were grown in either LB or DSM media and the activity of 
PyoeB-lacZ was examined as a function of growth (Fig. 2.5C). Expression was low 
during vegetative growth and increased upon entry into transition/stationary phase. 
This suggests that YoeB may normally function during transition phase, perhaps to 
stabilize the cell wall against autolysis in response to energy depletion. 
Dissection of the yoeB promoter region. To define regulatory elements involved in 
yoeB expression, I mapped the +1 site of transcription using 5’ RACE-PCR and 
constructed a nested series of transcriptional fusions (Fig. 2.6A). β-galactosidase 
activity was measured in the presence and absence of 2 μg/ml vancomycin (Fig. 2.6B). 
A region of 68 bp upstream of the +1 of transcription was sufficient for maximal 
induction levels. Although activity of the –42 fusion was diminished (14), induction 
was still evident. As expected, the –22 fusion did not show any activity. To confirm 
that the same minimal promoter region could mediate induction by 10 mM diamide, 
slot blot analyses were performed (Fig. 2.6C). Comparable induction levels were 
observed for fusions -514, -68 and +18, confirming that the minimal promoter and 
regulatory elements are within the –42 to +18 region. Since most positive-acting 
transcription factors bind upstream of the -35 element, this result is most consistent 
with the hypothesis that yoeB is under negative control (see Discussion). Indeed, 
inspection of the promoter and regulatory region reveals the presence of a candidate 
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Figure 2.6. Dissection of the yoeB promoter region. (A) Schematic of yoeB promoter 
region. Capital letters designate bases that are identical in B. subtilis 168,  B. 
licheniformis 14580, and B. amyloliquefaciens FZB45. Conserved -35, -10 promoter 
elements and the RBS are designated by grey overlines and the start of translation by a 
triangle, dashed underlines designate the conserved 8 bp direct repeat. Dotted lines 
represent promoter fusions. (B) β-galactosidase assay for induction of various 
promoter fusions by vancomycin (2 μg/ml) (Grey) compared to uninduced controls 
(Black). Results are representative of two independent experiments, and are the 
average of two independent samples. (C) Graphic representation of RNA slot blot 
analysis for expression of PyoeB-lacZ. RNA samples extracted from strains containing 
the different promoter fusions either uninduced or induced by 10 mM diamide were 
applied to the blot. The blot was hybridized with a probe for lacZ, and the resulting 
signals were quantified with the ImageQuant data analysis software. Results are 
representative of two independent experiments. 
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regulator binding site (the 8 bp direct repeat: TATTGTAA-N12-TATTGTAA) that is 
also conserved in the promoter regions of the yoeB homologs in B. licheniformis and 
B. amyloliquefaciens (Fig. 2.6A).  
 
5. Discussion 
Bacteria must develop mechanisms for dealing with a variety of stresses. The 
genes induced by a particular stress define a stimulon, and often include genes 
controlled by several different regulatory proteins or pathways (regulons). 
Transcriptome analysis of the vancomycin stimulon revealed that yoeB is one of the 
most highly induced genes (~19 fold). As summarized here (Table 2.2), yoeB is also 
induced by several other inhibitors of cell-wall biosynthesis (including D-cycloserine, 
fosfomycin, and oxacillin), lipid-targeting antibiotics such as triclosan and membrane 
active compounds (16), and disulfide stress (22). I have confirmed these results here, 
and additionally provide evidence that yoeB is induced upon entry into stationary 
phase (Fig. 2.5).  
YoeB is a 181 aa protein with a predicted amino-terminal signal sequence. 
Here, I demonstrate that YoeB co-fractionates with the cell wall (Fig. 2.3). 
Interestingly, YoeB was recently detected as a cell wall protein induced by 1% acidic 
phytate (YoeB had not been detected in any prior proteome analyses), a condition that 
results in apparently increased levels of several autolysins (1). The only known 
homologs of YoeB are a hypothetical protein 01880 from B. amyloliquefaciens (77% 
identity and 81% similarity) and YoeB from B. licheniformis (65% identity and 78% 
similarity) (Fig. 2.7).  
It is intriguing to note that YoeB has a low level of identity (25% identity, 47% 
similarity) with an ~80 aa region of MecA1 from Staphylococcus sciuri (Fig. 2.7). The 
corresponding mecA1 gene is thought to be the ancestor of the mecA methicillin 
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Figure 2.7. Alignment of YoeB from B. subtilis (Bsu), B. amyloliquefaciens  (Bam) 
and B. licheniformis (Bli). The predicted signal sequence cleavage site is after Ala23 
as designated by the black triangle. Boxed sequences are an alignment of partial 
sequences from S. sciurii (Ssc) PBP2a (aa 73-131 of 665), S. sciurii MecA1 (aa 61-
131 of 666) and B. subtilis (Bsu) PbpC (aa 64-140 of 668). Black shading (non-boxed 
sequences): conserved in all three YoeB proteins. Black shading (boxed sequences): 
conserved in all six proteins. Dark grey shading (non-boxed sequences): conserved in 
two out of three YoeB proteins. Light grey shading (boxed sequences): conserved in at 
least four of the six proteins. Alignments performed using ClustalW and shaded using 
Genedoc program (http://www.psc.edu/biomed/genedoc). 
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resistance gene in Staphylococcus aureus encoding PBP2a (44). PBP2a has a low 
affinity for β-lactam antibiotics, and therefore allows continued cell wall synthesis in 
the presence of otherwise lethal levels of β-lactams (8). Despite the similarity to 
MecA proteins, YoeB is unlikely to function as a PBP: the region of homology 
between YoeB and PBP2a corresponds to an N-terminal extension found in high 
molecular mass PBPs of subclass B1 hypothesized to play a non-catalytic, structural 
role (24). In B. subtilis, PBP3 (PbpC) is also a member of this class and also has weak 
similarity to YoeB in this region.  
The most dramatic phenotype of a yoeB null mutant is an increased rate of 
lysis in response to treatment with cell wall antibiotics that target several different 
steps of the PG biosynthetic pathway. Direct measurements of viable cell counts 
demonstrates that this increased rate of lysis is correlated with an increased rate of cell 
death in D-cycloserine treated cultures. An increased rate of autolysis could be 
explained by an imbalance in autolysin composition or activity and/or an alteration in 
the cell wall structure. I currently favor a model in which YoeB modulates the activity 
of autolysins. Evidence for this model includes the localization of YoeB to the cell 
wall and the altered rates of cellular autolysis observed in both antibiotic-treated and 
nutrient depleted cells. It is formally possible that YoeB could bind to PG, and thereby 
impede autolysin action. However, the low abundance of YoeB (~50-100 molecules 
/cell) makes this model less attractive. 
B. subtilis encodes as many as 35 different proteins known or postulated to 
have PG hydrolase activity (40). It is currently unclear how YoeB affects autolysin 
activity, and the large number of autolysins makes identification of a specific target 
challenging. An increased rate of autolysis was still observed even when the effect of 
yoeB was tested in a sigD mutant background in which the major vegetative autolysins 
(LytC and LytD) are present at greatly reduced levels (data not shown). However, cell 
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lysis in response to the metabolic poison sodium azide was unaffected in a yoeB 
mutant (Fig. 2.2B), suggesting that under conditions which strongly activate autolytic 
activity there was no gross difference in either autolysin levels or activity. The levels 
of autolysins (and other cell wall binding proteins) extracted from WT and yoeB 
mutant cells were indistinguishable by SDS-PAGE, 2D-gel electrophoresis, 
zymographic analysis, and autolysin activity assays (data not shown and H. 
Antelmann, personal communication). Nor were there any obvious differences in PG 
structure (D. Popham, personal communication). These results are most consistent 
with a model in which YoeB moderates the activity of one or more autolysins, 
presumably by protein-protein interaction.  
Promoter dissection experiments demonstrate that the minimal regulatory 
region for yoeB is included within the region from –42 to +18. This region contains 
recognition elements for the σA holoenzyme together with a 8 bp direct repeat element 
conserved in the two orthologous genes from B. licheniformis and  
B. amyloliquefaciens (Fig. 2.6A). Notably, the genes are not found in the same genetic 
context in these organisms. In B. subtilis and B. amyloliquefaciens, yoeB is 
monocistronic and divergently transcribed from yoeA, which encodes a protein similar 
to a Na+ driven multidrug efflux pump in B. cereus (58% identity). In B. licheniformis, 
yoeB is divergent from BLi01309, a putative cell wall-binding protein containing a 
LysM domain found in enzymes involved in bacterial cell wall degradation. BLi01309 
is homologous to YocH in B. subtilis, a putative autolysin under the control of the 
YycFG TCS (15). The proximity to yocH in B. licheniformis led me to hypothesize 
that YoeB might regulate YocH activity specifically. However, a yoeB yocH double 
mutant in B. subtilis is indistinguishable from the yoeB single mutant in the rate of 
lysis in response to antibiotic treatment (data not shown).   
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 My initial efforts to identify the negative regulator(s) of yoeB were 
unsuccessful. Selection for mini-Tn10 transposon insertions that led to constitutive 
expression of a yoeB-cat-lacZ transcriptional fusion did not identify any candidates, 
nor did biochemical experiments using the yoeB regulatory region to affinity purify 
DNA-binding proteins. However, recent work from K. Devine’s laboratory (personal 
communication) has identified yoeB as a direct target for negative regulation by YycF, 
the response regulator of the essential YycFG TCS. This is entirely consistent with my 
promoter dissection studies and there is clear similarity between the proposed YycF 
consensus site (15) and the conserved repeat motifs noted above in the yoeB regulatory 
region. The essential nature of the yycFG TCS may also account for my inability to 
identify this system using Tn10 mutagenesis.  
The YycFG TCS functions to maintain cell wall homeostasis by positively 
regulating the expression of cell division (ftsZA) and wall synthesis functions 
(autolysins) (15). Similarly, the orthologous system in Streptococcus pneumoniae 
activates expression of the essential murine hydrolase PcsB (32). I suggest that 
activation of the B. subtilis YycFG system during growth both enables autolysin 
expression and cell wall expansion while repressing the expression of YoeB, shown 
here to inhibit autolytic activity. Conversely, upon nutrient depletion or exposure to 
antibiotics that inhibit cell wall synthesis, a decrease in active YycF will lead to a 
reduced synthesis of autolysins and a concomitant increase in expression of YoeB. 
In summary, my studies demonstrate that YoeB is a cell wall-associated 
protein that decreases the rate of lysis in response to cell-wall targeting antibiotics and 
upon nutrient depletion. The lack of apparent changes in overall autolytic activity or 
PG structure leads me to prefer a model in which YoeB directly interacts with one or 
more autolysins to down-regulate their activity. In light of the recent findings linking 
yoeB regulation to YycFG, one or more of the autolysins controlled by this TCS are 
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likely candidates, however it does not seem that YoeB is regulating a single autolysin 
since double mutants of yoeB and various autolysins under the control of the YycFG 
TCS did not decrease the rate of lysis to a level comparable to that seen with WT cells 
(data not shown). However, recent data has suggested that YoeB binds to three 
autolysins: LytF, LytE and CwlS, and completely inhibits their activity (38). The loss 
of this control mechanism in yoeB mutants leads to a decrease in the structural 
integrity of the cell wall under conditions of impaired cell wall synthesis or in 
response to growth transitions.  
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CHAPTER THREE 
A GntR family transcriptional regulator in Bacillus subtilis  
modulates resistance to cell wall-targeting antibiotics  
 
1. Introduction 
Antibiotic efflux pumps constitute a widespread and basic resistance 
determinant in bacteria, making up on average more than 10% of the transporters in an 
organism (17). These pumps are of great interest due to their broad substrate range, as 
well as the possibility that induction of pump expression by a certain substrate will 
result in resistance to other substrates (cross-resistance) (26). One of the major classes 
of these transporters is the ATP-binding cassette (ABC) transporter family, shown to 
effectively efflux structurally dissimilar antibiotic compounds (17, 24). A typical ABC 
transporter is usually encoded by genes in the same operon, and is comprised of two 
hydrophobic membrane-spanning domains (MSD), and two hydrophilic nucleotide-
binding domains (NBD) localized on the cytoplasmic side of the membrane, which 
provide the energy for the transport process (19). 
Although constitutively expressed multidrug ABC transporters have been 
reported (22), they are usually subject to various mechanisms of transcriptional 
regulation. An adjacent transcriptional regulator can act by binding directly to the 
effector molecule, leading to expression of the transporter as exemplified by the 
Lactococcus lactis LmrR transcriptional repressor that regulates the expression of the 
LmrCD multidrug ABC transporter (1). LmrR is thought to bind to toxic compounds 
that have permeated the cell membrane leading to a conformational change and 
subsequent derepression of lmrCD (1). However, global regulators responding to 
different sets of signals can also affect transcription of these systems. In Escherichia 
coli, inactivation of the MarR regulator leads to production of the MarA 
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transcriptional activator, which can then activate the transcription of the acrAB-tolC 
transport complex (9). 
One approach to characterizing the regulatory networks involved in stress 
responses is to study transcriptional expression profiles in response to varying 
compounds. Previously we have investigated the transcriptional responses of B. 
subtilis to treatment with different cell wall active antibiotics (6, 14). Vancomycin led 
to the rapid induction (3 min.) of ~100 genes, including the regulons controlled by the 
extracytoplasmic function (ECF) σ factors, σW and σM (6). Among the genes induced 
by vancomycin, but not known to be under the control of either of these ECF σ 
factors, were genes in the ytrABCDEF operon. The ytrABCDEF operon was proposed 
to encode for a putative ABC transport system involved in acetoin utilization during 
stationary phase and sporulation, since deletion of the operon did not affect production 
of acetoin, but did reduce the efficiency of acetoin reuse (27). Expression of this 
operon was shown to be under the control of a GntR-type repressor encoded by the 
first gene of the operon, ytrA. GntR-type regulators have previously been reported to 
regulate antibiotic production and morphogenesis in Streptomyces coelicolor (11), as 
well as the expression of efflux pumps affecting resistance of Staphylococcus aureus 
to quinolones and unexpectedly to β-lactams, albeit those with more lipophilic side-
chains that could partition to the membrane (23). 
I here demonstrate that YtrA regulates the expression of both the ytrABCDEF 
operon and an additional locus, ywoB, and define the regulatory elements of these 
promoters. In addition I show that both PytrA and PywoB are induced by cell-wall 
targeting antibiotics, and that ywoBCDEF is involved in resistance to bacitracin. Thus 
I propose that YtrA functions as a component of a cell envelope response mechanism 
involved in resistance to cell-envelope targeting compounds.  
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2. Materials and Methods 
Bacterial strains and growth conditions. All B. subtilis strains used were derivatives 
of CU1065 (W168 trpC2 attSPβ). Escherichia coli strain DH5α was used for standard 
cloning procedures. Bacteria were grown in Luria-Bertani (LB) medium at 37oC with 
vigorous shaking. Antibiotics were added to the growth medium when appropriate: 
100 μg/ml ampicillin and 34 μg/ml chloramphenicol for E. coli, and 1μg/ml 
erythromycin plus 25 μg/ml of lincomycin (MLS, macrolide-lincomycin-
streptogramin B resistance), 10 μg/ml chloramphenicol, 100 μg/ml spectinomycin and 
10 μg/ml kanamycin for B. subtilis. OD600 readings were taken on a Spectronic 21 
(Milton Roy) spectrophotometer.  
Sensitivity to cell wall targeting antibiotics and was measured by growing the 
different strains in LB medium at 37oC with vigorous shaking. Antibiotics were added 
at the indicated concentration during early exponential growth (OD600 ~ 0.25). Lysis 
was monitored by measuring the decrease of OD600 at 30 min intervals.  
Construction of null mutants. Chromosomal deletions were created in the CU1065 
background using long-flanking homology PCR (LFH-PCR) as described (14) with 
the following changes: flanking fragments were amplified using iProof  DNA 
Polymerase (Bio-Rad) and the flanking fragments and antibiotic resistance marker 
were joined using Expand Long Template PCR System (Roche). A detailed protocol is 
available at: 
http://www.micro.cornell.edu/faculty/helmann/supplemental%20index.htm. 
Construction of the ytrA null mutant was created using the pMAD shuttle vector (2). 
Briefly, a DNA fragment containing an in-frame deletion of the ytrA sequence was 
PCR amplified using primers #3676, #3677, #3678 and #3679. this fragment was then 
digested with EcoRI and BamHI, and cloned into vector pMAD, which contains a 
constitutively expressed bgaB gene, as well as being replication-thermosensitive (2), 
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resulting in plasmid pLS39. The sequence of the inserts was verified by DNA 
sequencing (Cornell DNA sequencing facility). B. subtilis WT strain CU1065 was 
transformed with pLS39, plated on media containing MLS and 80 μg/ml 5-Bromo-4-
choloro-3-indoxyl-beta-D-galactopyranoside (X-gal) and incubated at 30oC. Blue 
colonies were inoculated into LB-MLS liquid broth and grown at 40oC for 6-8 hours, 
and then plated (in dilution) on LB-MLS-X-gal plates and incubated at 40oC. 
Resulting blue colonies were inoculated into LB liquid broth and grown for 6 hours at 
30oC, next for 3 hours at 40oC, and then plated (in dilution) on LB-X-gal plates and 
incubated at 40oC. Resulting white colonies were restreaked to LB-X-gal and LB-
MLS-X-gal plates (to verify loss of MLSr ). The ytrA deletion was verified by PCR 
amplification of the region followed by DNA sequencing (Cornell DNA sequencing 
facility). Primer sequences used for mutant construction are detailed in Table 3.1. 
Construction and analysis of transcriptional fusions. DNA fragments of the ytrA 
and ywoB regulatory regions were PCR amplified using primers: #3700 #3701 (PytrA) 
and #3734 #3735 (PywoB). The fragments were digested with EcoRI and BamHI, and 
cloned into vector pDG1661, containing a promoterless lacZ gene (10), resulting in 
plasmids pLS33 and pLS34, respectively. The sequence of the inserts was verified by 
DNA sequencing (Cornell DNA sequencing facility). B. subtilis strains were 
transformed to Cmr with the ScaI-linearized plasmids which integrated into the amyE 
locus. For quantitative measurements of β-galactosidase activity, cells were grown in 
either LB medium at 37oC with vigorous shaking, and samples were collected at 
different OD600 points. 
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Table 3.1. Strains, plasmids and oligonucleotides used in this study 
 
 Description Created / 
reference 
E.coli   
DH5α φ80lacZΔm15 recA1 endA1 gyrA96 thi-1 hsdR17 (rK-, 
mK+) supE44 relA1 deoR Δ(lacZYA-argF)U169 
Lab strain 
BL21(DE3)pLysS F- ompT hsdSB (rB-mB-) gal dcm(DE3) / pLysS Novagen 
HE5322 BL21(DE3)pLysS  containing pLS36 pLS36 → 
BL21(DE3)pLysS 
B. subtilis   
CU1065 W168 trpC2 attSPβ Lab strain 
HB5447 CU1065  ytrABCDEF::kan LFH-PCR → 
CU1065 
HB5448 CU1065 ywoBCDEF::MLS LFH-PCR → 
CU1065 
HB5449 CU1065 ywoHG::spc LFH-PCR → 
CU1065 
HB5450 CU1065 ytrABCDEF::kan ywoBCDEF::MLS LFH-PCR → 
HB5447 
HB5451 CU1065 ytrABCDEF::kan ywoHG::spc LFH-PCR → 
HB5447 
HB5452 CU1065 ywoBCDEF::MLS ywoHG::spc LFH-PCR → 
HB5448 
HB5453 CU1065 amyE::PytrA-lacZ pLS33 → CU1065 
HB5454 CU1065 ytrABCDEF::kan amyE::PytrA-lacZ pLS33 → HB5447 
HB5455 CU1065 ywoBCDEF::MLS amyE::PytrA-lacZ pLS33 → HB5448 
HB5456 CU1065 CU1065 ywoHG::spc amyE::PytrA-lacZ pLS33 → HB5449 
HB5457 CU1065 amyE::PywoB-lacZ pLS34 → CU1065 
HB5458 CU1065 ytrABCDEF::kan amyE::PywoB-lacZ pLS34 → HB5447 
HB5459 CU1065 ywoBCDEF::MLS amyE::PywoB-lacZ pLS34 → HB5448 
HB5460 CU1065 CU1065 ywoHG::spc amyE::PywoB-lacZ pLS34 → HB5449 
HB5485 CU1065 with in-frame markerless deletion of ytrA pLS39 → CU1065 
HB5486 CU1065 with in-frame markerless deletion of ytrA 
ywoBCDEF::MLS 
LFH-PCR → 
HB5485 
HB5486 CU1065 with in-frame markerless deletion of ytrA 
amyE::PytrA-lacZ 
pLS33 → HB5485 
HB5486 CU1065 with in-frame markerless deletion of ytrA 
amyE::PywoB-lacZ 
pLS34 → HB5485 
HB6726 CU1065 ytrA::kan LFH-PCR → 
CU1065 
   
Plasmids   
pDG1661 Vector for integration of lacZ fusions at amyE locus (10) 
pET-11a Overexpression vector Novagen 
pMAD Vector for marker free allelic replacement (2) 
pLS33 PytrA-lacZ in pDG1661 This work 
pLS34 PywoB-lacZ in pDG1661 This work 
pLS36 pET-11a containing a NdeI- BamHI fragment encoding 
for ytrA 
This work 
pLS39 pMAD containing a 1.4-kb BamHI-EcoRI fragment for 
in-frame deletion of ytrA 
This work 
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Table 3.1. (Continued) 
 
Primers   
# Name Sequence* 
3676 ytrA up fwd (BamHI) cgcggatcccatctccagcaatgtatgcag 
3677 ytrA up rev cattttttttgcctccttcgtaaatgggtgttgagcttcttggatcgatttg 
3678 ytrA do fwd caaatcgatccaagaagctcaacacccatttacgaaggaggcaaaaaaaatg 
3679 ytrA do rev (EcoRI) ccggaattcttccacacttttggcttcagc 
3700 PytrA fwd (EcoRI) ccggaattcgattgactttgtgagtcaaagt 
3701 PytrA rev (BamHI) cgcggatccccctactttctatacgatctga 
3702 ytrA up fwd (LFH) aattcatgtgcctccttgcg 
3703 ytrA up rev (kan) CCTATCACCTCAAATGGTTCGCTGgtgttgagcttcttggatcg 
3704 ytrA do fwd (kan) CGAGCGCCTACGAGGAATTTGTATCGaaaccaacgtgctgacagcg 
3705 ytrA do rev (LFH) aacttgtcctcttccttcgc 
3734 PywoB fwd (EcoRI) ccggaattctcatgtaagatttcctgacatg 
3735 PywoB rev (BamHI) cgcggatccccctcagtgtattatttgatgt 
3736 ywoB up fwd (LFH) tgtaccgtctttccgtttgcc 
3737 ywoB up rev (MLS) GAGGGTTGCCAGAGTTAAAGGATCgggaatcgacttgcgtaccg 
3738 ywoB do fwd (MLS) CGATTATGTCTTTTGCGCAGTCGGCcgttagatcctgattcacctgc 
3739 ywoB do rev (LFH) ttgatgagagtggtaagctttcc 
3740 ywoH up fwd (LFH) ccgaggtcaataccaatatccc 
3741 ywoH up rev (spc) CGTTACGTTATTAGCGAGCCAGTCgatgaatgaggtgtctgttgacgta 
3742 ywoG do fwd (spc) CAATAAACCCTTGCCCTCGCTACGgctgaaggaaaagtgtctattgcag 
3743 ywoG do rev (LFH) cacagttgcaggcaatgtgg 
4020 ytrA fwd (NdeI) gtacgcatatgattcaaatcgatccaagaagctc 
4021 ytrA rev (BamHI) gcggatccatcattttttttgcctcccttcac 
4153 ytrA GPS1 ttcgcaataatgatcgttgc 
4154 ytrA GPS2 gtgttgagcttcttggatcg 
4155 ywoB GPS1 aacagctgccaggatttcac 
4156 ywoB GPS2 ccaattaccactttcgccag 
* Capped letters indicate sequences complementary to antibiotic resistance genes. Underlined 
sequences indicate restriction sites. 
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To test promoter induction, cells were grown in LB until an OD600 ~ 0.4, and then the 
culture was split into aliquots, which were challenged with either vancomycin (2 
μg/ml final), bacitracin (20 μg/ml final) and ramoplanin (10 μg/ml final). The cultures 
were returned to 37oC, and samples were collected after 30 min. β-galactosidase 
activity was measured according to the method of Miller (15) except that cells were 
lysed by the addition of lysozyme to a final concentration of 20 μg/ml followed by a 
30 min incubation at 37oC. 
RNA isolation and 5’-RACE. Strain HB5485 (CU1065 containing in-frame deletion 
of ytrA) was grown in LB (37oC with vigorous shaking) to mid-exponential stage 
(OD600 ~ 0.4), and RNA isolation and was performed using the RNeasy mini kit 
(Qiagen). RNA was subsequently DNase treated with TURBO DNA-freeTM (Ambion) 
and precipitated overnight. The RNA was dissolved in RNAse free water and 
quantified using a NanoDrop spectrophotometer (Nanodrop Tech. Inc., Wilmington, 
DE). 2 μg of total RNA was used with the 5’ random amplification of cDNA ends 
(RACE) kit (Invitrogen) according to the manufacturer’s specifications (primers 
#4153, #4154, #4155, #4156). Resulting DNA fragments were sequenced at the 
Cornell DNA sequencing facility.  
Hierarchical clustering analysis. Hierarchical clustering for whole genome datasets 
was performed using Cluster 3.0 (7). Transcriptome datasets were derived from 
unpublished results from our lab or a previously published study (13). The datasets 
represent the following treatment conditions and times: 16 μg/ml D-cycloserine (10 
min), 0.25 μg/ml oxacillin (10 min), 1.0 μg/ml moenomycin (20 min), 100 μg/ml 
bacitracin, (5 min) 2 μg/ml vancomycin (10 min), 0.5 μg/ml ristocetin (10 min), 5 
μg/ml ramoplanin (10 min), 0.03 μg/ml gramicidin A (10 min), 0.125 μg/ml monensin 
(10 min), 64 μg/ml polymyxin B (10 min), 64 μg/ml Triton –X- 114 (10 min), 64 
μg/ml puromycin (10 min), 0.5 μg/ml tetracycline (10 min), and 4 μg/ml 
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chloramphenicol (10 min). The hierarchical clustering was visualized using TreeView 
(8).   
Overproduction and purification of YtrA. YtrA was purified using E.coli strain 
HE5322; BL21(DE3)pLysS (Novagen) containing pLS36, a pET11a derivative, which 
places ytrA under the control of a T7lac promoter. A 1-liter culture was grown from a 
fresh colony of HE5322 in LB broth containing 0.5% glucose, 100 μg/ml ampicillin 
and 34 μg/ml chloramphenicol to enhance plasmid stability. At an OD600 of 0.4, 
isopropyl-β-D-thiogalactopyranoside (IPTG; Gold BioTechnology) was added to 
1mM, and growth continued for 2 hours, at which point cells were harvested. Cell 
pellets were resuspended in 10 ml resuspension buffer (40 mM Tris-HCl [pH 8.0],  
1 mM EDTA, 5% [vol/vol] glycerol and 1 mM dithiothreitol [DTT]) to which 1 tablet 
of Complete mini, EDTA-free protease inhibitor cocktail (Roche) was added. Cell 
suspension was disrupted by freeze-thawing followed by pulsed sonication, and 
clarified by 15 min centrifugation. The resulting supernatant was applied to a heparin 
column. Bound proteins were eluted with a NaCl gradient (0.2 to 1M) in elution buffer 
(20mM Tris-HCl [pH 8.0], 1mM EDTA, 5% [vol/vol] glycerol and 1mM DTT). 
Samples were loaded onto a 15% sodium dodecyl sulfate -polyacrylamide gel 
electrophoresis (SDS-PAGE) gel to identify the fractions containing YtrA. Pooled 
samples containing YtrA were then loaded onto a Bio-Rad Bio-ScaleTM Mini Macro-
Prep High S Cartridge, and proteins were eluted with a 0-1.0 M NaCl gradient in 
elution buffer (20mM Tris-HCl [pH 7.0], 1mM EDTA, 5% [vol/vol] glycerol and 
1mM DTT). Samples were loaded onto a 15% SDS-PAGE gel to identify the fractions 
containing YtrA, which were then pooled and dialyzed into buffer (20mM Tris-HCl 
[pH 8.0], 1mM EDTA, and 1mM DTT) containing 50% glycerol before storage at 
 –20oC.   
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Electrophoretic mobiolity shift assay (EMSA). PCR fragments containing either 
PytrA (274 bp; primers #3700 #3701), PywoB (192 bp; primers #3734, #3735) and the 
control non-specific PyoeB (106 bp) were amplified and end-labeled with T4 
polynucleotide kinase (PNK; New England BioLabs) and [γ-32P]ATP. Increasing 
amounts of YtrA (0-160 nM) were incubated at room temperature for 15 min with the 
labeled promoters in a total volume of 10 μl binding buffer (20 mM Tris-HCl [pH 
8.0], 5% [vol/vol] glycerol, 50 mM NaCl, 50 μg/ml bovine serum albumin [BSA] and 
5 μg/ml sheared salmon sperm DNA). Samples were loaded on a 6% polyacrylamide 
gel prepared and run in 90mM Tris-Borate buffer with 2mM EDTA. The gel was dried 
and imaged on a Storm 840 PhosphorImage scanner (Molecular Dynamics) after 
overnight exposure of a PhosphorImage screen.  
 
3. Results and Discussion 
The ytrA and ywoB promoters are induced by glycopeptide antibiotics.  Previous 
transcriptome analyses have demonstrated that the ytr operon is induced by the 
glycopeptide antibiotic vancomycin (6) and the lipoglycodepsipeptide antibiotic 
ramoplanin (our unpublished data). Additional studies (13) have shown that this 
operon is also strongly induced by another glycopeptide antibiotic, ristocetin, but 
interestingly, not by other cell-wall targeting antibiotics (such as D-cycloserine, 
phosphomycin or oxacillin) or by antibiotics with other modes of action.  This 
promoted the classification of PytrA as a reporter indicative of compounds with a 
glycopeptide mode of action (12).  
To further study the expression patterns of the ytr operon I performed 
hierarchical clustering analysis using transcriptional profiles generated in our lab 
(ramoplanin and moenomycin) and by Hutter et al. (13) (Fig. 3.1). As expected, genes 
in the ytr operon clustered tightly, demonstrating strong induction by 
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Figure 3.1.  Hierarchical clustering analysis of gene expression in response to 
antibiotic stress. Antibiotic treatments indicated above. Gene expression data were 
clustered based on expression level. Red indicates induction, and green repression 
under the specified treatment condition.  
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Figure 3.2. Characteristic induction (log) profiles of the ytr, ywo, bce and lia operons. 
The expression level (fold induction) of all the genes in each of the operons was 
averaged for each of the antibiotic treatments. Datasets used include D-cycloserine 
(Cyc), oxacillin (Oxa), moenomycin (Moe), bacitracin (Bac), vancomycin (Van), 
ristocetin (Ris), ramoplanin (Ram), gramicidin A (Gra), monensin (Mon), polymyxin 
B (Pol), Triton –X- 114 (Tri), puromycin (Pur), tetracycline (Tet), and 
chloramphenicol (Chl).  Transcriptome expression data were derived from 
unpublished results from our lab or a previously published study (13).
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vancomycin, ristocetin and ramoplanin.  Additional genes demonstrated similar 
specific induction profiles: bceRS, encoded immediately downstream of ytrF, and 
ywoB (Fig. 3.2). Indeed ywoB had been previously proposed as an additional reporter 
for glycopeptide antibiotic compounds (12). In comparison, the liaIHGFSR operon, 
also known to be strongly induced by cell wall-targeting antibiotics such as 
vancomycin (6) and bacitracin (14), demonstrates a different induction profile (Fig. 
3.2), suggesting that the ytr and ywo operons might be under similar transcriptional 
control. 
Transcriptional fusions for PytrA and PywoB were induced in response to 
treatment with vancomycin and ramoplanin, but not bacitracin, (Fig. 3.3), albeit to a 
much lower level than that observed in a ytrA null background, suggesting that YtrA 
might still be partially bound to these promoters. Although I cannot exclude that YtrA 
may be sensing the antibiotics directly, it would seem more likely that it is sensing a 
signal caused by damage to the cell wall and/or membrane, since the antibiotics 
inducing these promoters affect different targets and are unlikely to enter the cell due 
to their size.  
To clarify the possible involvement of other regulators in the antibiotic 
induction of ytrA, I created a transcriptional fusion containing only a putative ECF σW 
promoter sequence located 73-bp downstream of the transcriptional start site identified 
(Fig 3.4). This fusion was not induced in an rsiW null background (data not shown), in 
which σW would be overexpresssed, indicating that its involvement in the regulation 
of ytrA is unlikely.  
YtrA binds specifically to the ytrA and ywoB promoters. Yoshida et al. 
mapped the transcriptional start site and identified a σA-dependent promoter sequence 
(TTGACT-17-TATTGT) 244-bp upstream of the ytrA translation start site, and  
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Figure 3.3.  PytrA and PywoB are derepressed in a ytrA null background, and are induced 
by glycopeptide antibiotics. Induction of PytrA and PywoB was measured by β-
galactosidase assays. Treatments included: untreated control (white bars), vancomycin 
(2 mg/ml; black bars), bacitracin (20 mg/ml; grey bars) and ramoplanin (10 mg/ ml; 
hatched bars). β-galactosidase results are the average (± SD) of at least four 
independent cultures. Labels on bottom indicate the background strain: WT; wild-type 
CU1065, A; ytrA in-frame deletion, AF; ytrABCDEF::kan, BF; ywoBCDEF::MLS and 
HG; ywoHG::spc.  
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proposed a 31-bp inverted repeat overlapping the transcriptional start site as a possible 
binding site for YtrA (Fig. 3.4). I used 5’ RACE-PCR to map the ywoB start of 
transcription (33-bp upstream of the translation start site), and identified a σA-
dependent promoter sequence, which contains a shortened spacer sequence 
(TTGACA-15-TATACT; Fig. 3.4). Further inspection of this promoter region 
revealed an inverted repeat sequence similar to that in PytrA overlapping the 
transcriptional start site (Fig. 3.4-3.5). 
In order to establish whether YtrA acts as a transcriptional regulator of both the 
ytr and ywo operons I constructed transcriptional fusions for PytrA and PywoB and 
introduced them into WT, ytrA in-frame deletion, ytrABCDEF::kan, 
ywoBCDEF::MLS and ywoGH::spc backgrounds. Both PytrA and PywoB were 
completely derepressed in a ytrA in-frame deletion or ytrABCDEF::kan background 
(Fig 3.3), suggesting that YtrA acts as a transcriptional repressor of both these 
promoters.  
To determine whether additional loci are controlled by YtrA I conducted a 
pattern search using the PytrA inverted-repeat motif identified the binding site in the 
ywoB promoter in addition to somewhat less conserved motifs containing varying 
spacing upstream of four additional candidate promoters (Fig. 3.5). Although these 
genes do not cluster with either ytr or ywo genes in our hierarchical clustering 
analysis, it does not rule out the possibility that these genes might be regulated by 
YtrA or other GntR-type regulators.  
To address whether the regulatory effect observed in vivo involved a direct 
interaction of YtrA with the ytrA and ywoB promoters, YtrA was overproduced in E. 
coli under the control of T7 RNA polymerase and purified to ~95%. Purified YtrA 
bound and shifted the promoters of both ytrA and ywoB at 5nM (Fig. 3.6), but did not  
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Figure 3.4. Arrangement of ytrABCDEF and ywoBCDEFGH operons. The schematic 
is drawn to scale and predicted functions are shown above genes. NBD; nucleotide-
binding domain. MSD; membrane spanning domain. Promoter sequences are detailed 
below schematic. -35, -10 and RBS elements are in bold, +1 of transcription and 
translation are in capital letters. The proposed σW promoter elements are indicated by 
grey underline. YtrA binding site is indicated by black arrows. 
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Figure 3.5. Alignment of Putative YtrA binding site. A binding site consensus search 
was performed using the SubtiList graphical interface 
(http://genolist.pasteur.fr/SubtiList/) for the inverted repeat motif found in the PytrA 
promoter. Alignment was performed using ClustalW and shaded using Genedoc 
program (http://www.psc.edu/biomed/genedoc). The conserved motif is detailed above 
the alignment. Italicized letters represent the second half of the inverted repeat 
sequence, capital letters represent conserved nucleotides within the binding site. 
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Figure 3.6.  Specific binding of YtrA to the ytrA and ywoB regulatory regions. 
Promoter region were end-labled using PNK and [γ-32P]ATP. Constant amounts of 
the specific ytrA or ywoB promoters were incubated with increasing amounts of YtrA 
protein and constant amounts of the non-specific yoeB promoter (NS).  
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bind to the control DNA fragment. Interestingly, increasing the concentration of YtrA 
(20nM for PytrA and 40nM for PywoB) resulted in a super shift of the promoter 
fragments, suggesting the possibility of multiple binding sites, and that no additional 
co-factors are required for YtrA binding.  
ywoBCDEF contributes to reduced lysis in response to bacitraicin. To test the 
involvement of the ytr and ywo operons in antibiotic resistance I constructed null 
mutants of the ytrABCDEF and ywoBCDEF operons by allelic replacement with a 
kanamycin or MLS resistance gene using LFH-PCR (25). In addition an in-frame 
markerless deletion of ytrA was constructed using the pMAD vector (2). Double 
mutants were constructed by further rounds of transformation. I next tested the 
sensitivity of these mutants to different classes of cell wall antibiotics. 
Surprisingly, none of the strains tested demonstrated increased or reduced 
sensitivity to vancomycin. However, exposure of logarithmically growing cultures of 
either the ytrABCDEF::kan or the ytrA in-frame deletion to the Lipid-II inhibitor 
bacitracin resulted in reduced lysis (as measured by a drop in OD600) compared to that 
of the WT strain (Fig. 3.7). Intrigued by this result, I wished to ascertain whether this 
was due to the derepression of the ywoBCDEF operon. Indeed, treatment of either the 
ytrABCDEF::kan ywoBCDEF::MLS or the ytrA in-frame ywoBCDEF::MLS with 
bacitracin resulted in WT levels lysis (Fig. 3.7). This reduced lysis in response to 
bacitracin due to overproduction of ywoBCDEF is especially intriguing due to the 
close proximity of ytr and ywo operons to the specific B. subtilis bacitracin resistance 
mechanisms bceRSAB (formerly ytsABCD) and bcrC (formerly ywoA). bcrC encodes 
for a undecaprenyl pyrophosphate phosphatase (3, 5), a secondary bacitracin-
resistance determinant, controlled by the extracytoplasmic function (ECF) sigma 
factors, σX and σM (5). bceRSAB are situated immediately downstream of the 
ytrABCDEF operon. bceRS encode for a two-component regulatory system which  
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Figure 3.7. The ywoBCDEF operon contributes to reduced lysis in response to 
bacitracin. B. subtilis wild-type (squares) and the isogenic ytrABCDEF  null mutant 
(triangles) and ytrABCDEF ywoBCDEF double null mutant (circles) were grown in 
LB were either untreated (filled symbols) or treated at OD600 ~ 0.25 (unfilled symbols) 
with 200 mg/ml bacitracin. Arrow indicates the time at which bacitracin was added. 
Results are representative of three independent experiments (average ± SD).  
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controls the expression of the BceAB ATP-binding cassette (ABC) transporter (16). 
The BceAB transporter system is responsible for exporting the majority of bacitracin 
in the cell, and inactivation of it results in a drastic decrease in resistance (4). 
However, an alternative model suggests that BceAB acts as a bacitracin importer, and 
that BceS is induced during bacitracin import (20). The tight clustering of the ytr and 
bce operons could perhaps indicate a regulatory connection between the two systems, 
or might be the result of readthrough off PytrA.  
In silico analysis of the YtrA regulon. The ytr operon arrangement (Fig. 3.4) is 
conserved in the B. subtilis close relatives Bacillus licheniformis (Bli), Bacillus 
amyloliquefaciens (Bam), as well as the more distant Bacillus pumilus (Bpu). In 
contrast, the operon structure of ywoBCDEF is not conserved. BLAST searches reveal 
that there is no apparent homolog of YwoB in either Bli or Bam, and only in Bam do 
ywoCDE and ywoGH appear in the same genetic context.     
YtrA is a representative of a subfamily of GntR regulators that possess a 
reduced C-terminal domain, and are predicted to bind an inverted-repeat operator 
sequence in an anti-parallel dimer configuration (21). YtrA regulates the ytrABCDEF 
operon proposed to encode for an ABC transport system involved in acetoin utilization 
but not its production (27).  
Based in part on the observation that ytrABCDEF is expressed as a single 
transcript during stationary phase, Yoshida et al. suggested a model whereby YtrB and 
YtrE are situated in the inner side of the cytoplasmic membrane and act as the 
nucleotide-binding domain (NBD) providing energy for transport through ATP 
hydrolysis, YtrC and YtrD are the membrane-spanning domains (MSD) comprising 
the permease, while YtrF is proposed to act as the periplasmic substrate-binding 
lipoprotein. Together these proteins form an integrated transport system for the import 
of acetoin, although acetoin was not found to induce its expression (27).  
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However, an analysis of B. subtilis ABC transport systems (19) classified 
YtrBCD and YtrEF as separate ABC export systems, containing two (YtrCD) or one 
(YtrF) MSD. In addition, YtrF is predicted to be a cytoplasmic membrane integral 
membrane protein containing at least three transmembrane domains.  
Further analysis of the B. subtilis genome reveal another GntR-type regulator 
exhibiting a shortened C-terminal domain, yhcF. yhcF is located upstream of yhcGHI. 
YhcG and YhcH have been classified as ATPases related to the NBDs of antibiotic 
resistance systems, with YhcG clustering in the same sub-group as YtrB (21). yhcI 
encodes for a permease similar to a lantibiotic immunity protein in Bli, and a 
bacitracin transport permease in Bacillus thuringiensis. Interestingly, the yhcGHI 
operon was strongly induced by the cationic antimicrobial peptide LL-37 (18) 
Concluding remarks. The proximity of these regulators to ABC transporters, 
clustering and induction by antibiotics suggest they form a new group of 
transcriptional regulators controlling the expression of multi-drug efflux systems. 
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CHAPTER FOUR 
Phenotypic and transcriptomic characterization of Bacillus subtilis  
mutants with grossly altered membrane composition 
 
1. Summary   
The Bacillus subtilis membrane contains diacylglycerol-based lipids with at 
least five distinct headgroups that impart distinct physical and chemical properties to 
the lipid bilayer. Here, I describe the phenotypic characterization of mutant strains 
lacking one or more of the following lipids: glycolipids (ugtP mutants), 
phosphatidylethanolamine (pssA and psd mutants), lysylphosphatidylglycerol (mprF), 
and cardiolipin (ywnE and ywjE). Alterations of membrane lipid headgroup 
composition are generally well tolerated by the cell and even severe alterations lead to 
only modest effects on growth proficiency. Mutants with decreased levels of 
positively charged lipids display an increased sensitivity to a cationic antimicrobial 
compounds and cells lacking glycolipids are sensitive to the lantibiotic sublancin and 
are defective in swarming motility. A quadruple mutant strain (ugtP pssA mprF 
ywnE), with a membrane comprised predominantly of phosphatidylglycerol, is viable 
and grows at near wild-type rates, although it forms long, coiled filaments. 
Transcriptome comparisons identify numerous regulons with altered expression in 
ugtP mutant cells, the pssA mprF ywnE triple mutant, and the uptP pssA mprF ywnE 
quadruple mutant. These effects include a general decrease in expression of the SigD 
and FapR regulons, and increased expression of cell envelope stress responses 
mediated by σM and the YvrGHb two-component system.  
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2. Introduction 
The cytoplasmic membrane forms an essential permeability barrier and is a 
defining feature of life. In most bacteria, the membrane is a lipid bilayer composed of 
fatty esters linked to sn-glycerol-3-phosphate (G3P) (45).  These complex lipids vary 
not only in the length and modifications of the acylated fatty acid groups but also in 
the composition of their headgroups, which differ significantly in charge and 
propensity to form non-bilayer structures within the membrane. The membrane of the 
soil bacterium Bacillus subtilis is a complex structure comprised mainly of the anionic 
phospholipid phosphatidylglycerol (PhG) and the zwitterionic 
phosphatidylethanolamine (PhE). Other components include a relatively large amount 
(~30%) of neutral glycolipids (GL), a variable amount of positively charged 
lysylphosphatidylglycerol (LPG), and a small amount of anionic cardiolipin (CL) (see 
Fig. 1.3).  
The complex composition of the membrane is presumed to be important since 
the physical properties of membrane lipids influence many cell processes including 
division (42), DNA replication (21), and protein transport (12). For example, the 
anionic lipids PhG and CL mediate the cycling of the DNA replication protein DnaA 
from the ADP-DnaA to ATP-DnaA (active) state, and inhibit the binding of DnaA to 
oriC via sequestration (6). E. coli cells with reduced amounts of anionic phospholipids 
accumulate outer membrane proteins in the cytoplasm and some proteins insert 
incorrectly into the membrane (59). Furthermore, CL and PhE facilitate the formation 
of non-bilayer structures (12) important in cell division and sporulation (34). Recent 
evidence suggests that these various lipid species may assort into spatially distinct 
lipid micro-domains (55), which in turn may affect the localization of membrane 
proteins (34). In B. subtilis CL-rich and PhE-rich domains are localized to the septal 
regions and the poles (25, 40), corresponding with the FtsZ-dependent subcellular 
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localization of the lipid biosynthesis enzymes PssA, YwnE, and PgsA 
(phosphatidylglycerophosphate synthase) (40).  
In B. subtilis, membrane lipids are synthesized from the common precursor 
phosphatidic acid (PA) (Fig. 1.3). In the case of PhE, PA is converted to CDP-
diacylglycerol (CDP-DAG) which is condensed with serine and then rapidly 
decarboxylated to generate PhE. Condensation of CDP-DAG with glycerol-3-
phosphate followed by removal of the phosphate leads to PhG, the only essential 
complex lipid in B. subtilis. PhG can be further modified to form two minor complex 
lipids CL and LPG. CL is formed by the condensation of two PhG molecules by 
cardiolipin synthase (CLS). B. subtilis contains two CLS enzymes: the major form 
(YwnE; also called ClsA (25)) is expressed during vegetative growth, while the minor 
(YwjE) is involved in sporulation (25). LPG is formed when MprF transfers a lysyl 
group from lysyl-tRNALys to PhG. Finally, GL are created by dephosphorylation of 
PA to diacylglycerol which is then modified by the transfer of one or two glucose 
molecules from UDP-glucose by UgtP (24). Fatty acid synthesis and desaturation are 
controlled by the FapR (51), and DesRK (13) regulatory systems and both chain 
length and desaturation may be regulated by various stress conditions  (30, 31, 37,  
48). In contrast, little is known about how membrane headgroup composition is 
regulated, although the extracytoplasmic-function (ECF) σ factor σX has been shown 
to contribute to expression of PhE biosynthesis genes (10).  
Here, I report the characterization of a series of isogenic B. subtilis strains with 
altered membrane composition. Mutant strains were characterized for growth, 
antibiotic resistance, morphology, and alterations in global gene expression patterns. 
My results suggest that the cell can tolerate even large changes in membrane 
composition. Remarkably, B. subtilis retains viability and even rapid growth when the 
membrane is comprised predominantly, if not exclusively, of PhG.  
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3. Materials and Methods 
Bacterial strains and growth conditions. All B. subtilis strains used were derivatives 
of either CU1065 (W168 trpC2 attSPβ) or the related strain NCIB3610 (Table 4.1). 
Escherichia coli strain DH5α was used for standard cloning procedures. Bacteria were 
grown in Luria-Bertani (LB) medium, LB supplemented with 25 mM MgSO4 or 
modified minimal medium (8) at 37oC with vigorous shaking. Antibiotics were added 
to the growth medium when appropriate: 100 μg/ml ampicillin for E. coli, and 1 μg/ml 
erythromycin plus 25 μg/ml of lincomycin (MLS, macrolide-lincomycin-
streptogramin B resistance), 10 μg/ml chloramphenicol, 10 μg/ml kanamycin, 20 
μg/ml tetracycline and 100 μg/ml spectinomycin for B. subtilis. Sensitivity to nisin 
was measured by growing the different strains in LB and then adding the indicated 
concentration during early exponential growth (OD600 ~ 0.25). Sensitivity to sublancin 
was tested via spot-on-lawn assay. Lawns were created by inoculating 100 μl of mid 
exponential cultures into 2 ml of 0.7% LB agar. This was poured into one well of an 8 
well rectangular multidish (26 mm x 33 mm; Nunc). Once set, the plates were dried 
for 30 min in a laminar flow hood and 5 μl of strain JH642 and HB6164 (JH642 
sunA::kan; see Table 4.1), grown to an OD600 of 0.6, were spotted in the center of the 
well. Plates were incubated overnight at 37oC in an airtight container with moist paper 
towels to prevent drying.  
Construction of null mutants. Chromosomal deletions were created in CU1065 
background using long-flanking homology PCR (LFH-PCR) as described (33) with 
the following changes: flanking fragments were amplified using Pfu DNA Polymerase 
(Stratagene) and the flanking fragments and antibiotic resistance marker were joined 
using Expand Long Template PCR System (Roche). The Xylose inducible mutants 
were created by LFH using a spectinomycin resistance gene fused with the PxylA 
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region amplified from pTn7SX (7). Detailed protocol available at 
http://www.micro.cornell.edu/faculty/helmann/supplemental%20index.htm 
Primer sequences used for mutant construction are detailed in Table 4.1. 
The null mutants in the NCIB3610 background were created by SPP1-mediated 
transduction from the CU1065 strains harboring the mutation of interest as previously 
described (27). Transductants were tested for their ability to grow on the appropriate 
antibiotic and in minimal medium without the addition of tryptophan. 
Lipid extraction and thin layer chromatography. 10 ml of mid exponential cultures 
were centrifuged for 10 min at 4,500 x g and lipids were extracted from the pellet via a 
modified Bligh-Dyer method (5,28). Briefly, the cell pellet was resuspended in 100 μl 
ddH2O with the addition of perchloric acid to a final concentration of 1M. Cell 
suspension was then incubated at 0oC for 30 min, after which lipids were extracted by 
the addition of 1 ml methanol/chloroform/water (12:6:2 v/v) followed by incubation 
for 50 min on ice. Phase separation was achieved by the sequential addition of 0.3 ml 
water and 0.3 ml chloroform, after which suspensions were incubated overnight at –
20oC, and then centrifuged for 5 min at 720 x g at 4oC. The organic phase was then 
removed and dried under nitrogen. The lipids were resuspended in 20 μl of 
chloroform/methanol (2:1 v/v), spotted to silica gel 60 plates (VWR) and separated 
using the solvent mixture chloroform/methanol/water (65:25:4 v/v). Phospholipids 
were detected using molybdenum blue spray reagent (Sigma-Aldrich). PhG and PhE 
standards obtained from Sigma-Aldrich. 
Microscopy. Phase-contrast and fluorescence microscopy were performed using an 
Olympus BX61 epifluorescence microscope, with 40x UPlanFl (N.A. 0.75) and 100x 
UPlanApo (N.A. 1.35) objectives. The microscope is equipped with filter cubes for 
viewing fluorescein, 7-Aminoactinomycin D/Mitotracker Red, and DAPI/Hoechst 
 97
fluorescence. Images were acquired using a Cooke SensiCam and Slidebook software 
(Intelligent Imaging Inc).  Figures were assembled using Adobe Photoshop.  
Swarming motility assay. LB plates containing 0.7% agar were dried in a laminar 
flow hood for 30 min and then spotted in the center with 5 μl of mid-exponential 
cultures grown in LB medium. The plates were then dried for another 15 min and 
incubated overnight at 37oC. Figures were assembled using Adobe Photoshop. 
Construction and analysis of PsigM transcriptional fusion. DNA fragments of the 
sigM regulatory region were PCR amplified using primers: #2866 and #436 (Table 
4.1). The fragment were digested with HindIII and BamHI, and cloned into vector 
pDG1661 which contains a promoterless lacZ gene (20), resulting in plasmid pLS30. 
The sequences of the insert were verified by DNA sequencing (Cornell DNA 
sequencing facility). B. subtilis CU1065 and HB5346 (ugtP::MLS) were transformed 
to Cmr with the ScaI-linearized plasmid which integrated into the amyE locus, creating 
strains HB5423 and HB5426, respectively. For quantitative measurements of β-
galactosidase activity, strains HB5423 and HB5426 were grown in LB at 37oC with 
vigorous shaking, and samples were collected at different growth stages as determined 
by OD600. To test promoter induction, strains HB5423 and HB5426 were grown in LB 
until an OD600 ~ 0.3, and then the cultures were split into aliquots, which were either 
unchallenged or challenged with vancomycin (2 μg/ml) for 30 min. β-galactosidase 
activity was measured according to the method of Miller (36) except that cells were 
lysed by the addition of lysozyme to a final concentration of 20 μg/ml followed by a 
30 min incubation at 37oC. 
RNA isolation and Microarray analysis. Strains CU1065, HB5346 (ugtP, 
abbreviated as U), HB5437 (mprF pssA ywnE triple mutant; abbreviated as T), and 
HB5391 (ugtP mprF pssA ywnE quadruple mutant; abbreviated as Q) were inoculated 
into LB and grown at 37oC with vigorous shaking until an OD600 ~0.4, and RNA 
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isolation and was performed using the RNeasy mini kit (Qiagen). RNA was 
subsequently DNase treated with TURBO DNA-freeTM (Ambion) and precipitated 
overnight. The RNA was dissolved in RNAse free water and quantified using a 
NanoDrop spectrophotometer (Nanodrop Tech. Inc., Wilmington, DE). RNA was 
isolated from three biological replicates.  
 cDNA synthesis was performed using the SuperScriptTM Plus Indirect cDNA 
labeling System (Invitrogen) as per the manufacturer’s instructions using 20 μg of 
total RNA, then purified using the Qiagen MinElute kit (Qiagen, Maryland) and 
quantified with NanoDrop. Total cDNA was labeled overnight with Alexa Fluor 555 
or Alexa Fluor 647 (Invitrogen) then purified using the Qiagen MinElute kit (Qiagen, 
Maryland) and quantified with NanoDrop. Equal amounts (100-150 pmol) of labeled 
cDNA (WT/U, WT/T, WT/Q) were combined to a final volume of 15 μl, and 1 μl 
salmon sperm DNA (10 mg/ml, Invitrogen) plus 16 μl 2X  hybridization buffer (50% 
formamide, 10X SSC, 0.1% SDS) were added. cDNA mix was denatured at 95oC and 
hybridized 16-18 hours at 42oC to DNA microarray slides which had been 
prehybridized for at least 30 min at 42oC in 1% bovine serum albumin, 5X SSC (1X 
SSC is 0.15 M NaCl and 0.015 M sodium citrate), 0.1% sodium dodecyl sulfate 
(SDS), washed in water and dried. Following hybridization the slides were washed 
sequentially in: 2X SSC + 0.1% SDS for 5 min at 42oC, 2X SSC + 0.1% SDS for 5 
min at room temperature, 2X SSC for 5 min at room temperature, 0.2X SSC for 5 min 
at room temperature, and finally dipped in water and spun until dry. Arrays were 
scanned using a GenePixTM 4000B array scanner (Axon Instruments, Inc.). Our arrays 
are based on a B. subtilis oligonucleotide library manufactured by Sigma Genosys 
consisting of 4,128 oligonucleotides (65-mers) representing 4,106 B. subtilis genes, 10 
control oligonucleotides (from E. coli and Brome mosaic virus), and 12 random 
oligonucleotides. A single oligonucleotide was designed to represent each of the B. 
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subtilis genes as annotated in the genome data release R16.1 (26 April 2001) at the 
SubtiList website (http://genolist.pasteur.fr/SubtiList/). The arrays were printed onto 
poly-L-Lysine coated Corning CMT-Gap slides at the W.M. Keck Foundation 
Biotechnology Resource Laboratory, Yale University. Each array contains 8,447 
features corresponding to duplicates of each ORF-specific oligonucleotide, additional 
oligonucleotides of control genes, and 50% DMSO blank controls. 
 Raw data files were produced from the scanned images using the GenePix Pro 
4.0 software package (GPR files), and the red/green fluorescence intensity values were 
normalized such that the ratio of medians of all features was equal to 1. The 
normalized data was exported to Excel for analysis. The datasets were filtered to 
remove those genes that were not expressed at levels significantly above background 
in either condition (sum of mean fluorescence intensity <30). For analysis, we filtered 
to identify those genes that were altered at least 1.5-fold in signal intensity in at least 2 
of the 3 biological replicates (and excluding those genes with an opposing change in 
the third replicate). Microarray datasets and related files are available at NCBI GEO 
accession number (pending).  
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Table 4.1 Bacterial strains and primers used in this study  
 
 
Name genotype Created / source 
   
CU1065 W168 trpC2 attSPβ Lab strain 
NCIB3610  Wild type isolate BGSC # 3A1 
JH642 pheA1 trpC2 BGSC # 1A96 
HB6164 JH642 sunA::kan (9) 
HB5337 CU1065 mprF::kan LFH-PCR → CU1065 
HB5343 CU1065 psd::MLS LFH-PCR → CU1065 
HB5346 CU1065 ugtP::MLS LFH-PCR → CU1065 
HB5347 CU1065 ywnE::tet LFH-PCR → CU1065 
HB5348 CU1065 ywjE::kan LFH-PCR → CU1065 
HB5361 CU1065 pssA::spc  LFH-PCR → CU1065 
HB5362 CU1065 ywnE::cat LFH-PCR → CU1065 
HB5445 CU1065 ywjE::cat LFH-PCR → CU1065 
HB5344 CU1065 psd::MLS mprF::kan HB5337 chr DNA → HB5343 
HB5349 CU1065 ywjE::kan ugtP::MLS LFH-PCR → HB5348 
HB5350 CU1065 mprF::kan ugtP::MLS LFH-PCR → HB5337 
HB5387 CU1065 ywnE::cat mprF::kan LFH-PCR → HB5362 
HB5388 CU1065 mprF::kan pssA::spc  LFH-PCR → HB5337 
HB5438 CU1065 ugtP::MLS pssA::spc  LFH-PCR → HB5346 
HB5439 CU1065 ugtP::MLS ywnE::cat LFH-PCR → HB5346 
HB5440 CU1065 pssA::spc ywnE::cat LFH-PCR → HB5361 
HB5441 CU1065 ywnE::cat  ywjE::kan HB5348 chr DNA → HB5362 
HB5442 CU1065 ywnE::cat psd::MLS HB5343 chr DNA → HB5362 
HB5443 CU1065 pssA::spc ywjE::kan HB5348 chr DNA → HB5361 
HB5389 CU1065 ugtP::MLS mprF::kan pssA::spc  LFH-PCR → HB5350 
HB5390 CU1065 ugtP::MLS mprF::kan ywnE::cat LFH-PCR → HB5350 
HB5436 CU1065 ugtP::MLS pssA::spc ywnE::cat LFH-PCR → HB5438 
HB5437 CU1065 mprF::kan pssA::spc  ywnE::cat LFH-PCR → HB5388 
HB5391 CU1065 ugtP::MLS pssA::spc ywnE::cat mprF::kan LFH-PCR → HB5436 
HB5481 CU1065 ugtP::MLS pssA::spc mprF::kan ywnE::tet LFH-PCR → HB5389 
HB5482 CU1065 ugtP::MLS pssA::spc mprF::kan ywnE::tet ywjE::cat HB55445 chr DNA → HB5481 
HB5406 CU1065 pssA::spc-PxylA LFH-PCR → CU1065 
HB5407 CU1065 ybfM::spc-PxylA LFH-PCR → CU1065 
HB5461 NCIB3610 pssA::spc transduction → NCIB3610 
HB5462 NCIB3610 ugtP::MLS transduction → NCIB3610 
HB5463 NCIB3610 mprF::kan transduction → NCIB3610 
HB5464 NCIB3610 ywnE::cat transduction → NCIB3610 
HB5465 NCIB3610 ywjE::cat transduction → NCIB3610 
HB5466 NCIB3610 ugtP::MLS pssA::spc transduction → HB5462 
HB5467 NCIB3610 ugtP::MLS mprF::kan transduction → HB5462 
HB5468 NCIB3610  ywnE::cat ugtP::MLS transduction → HB5464 
HB5469 NCIB3610 ugtP::MLS ywjE::cat transduction → HB5462 
HB5470 NCIB3610 pssA::spc mprF::kan transduction → HB5461 
HB5471 NCIB3610 ywnE::cat pssA::spc transduction → HB5464 
HB5472 NCIB3610 pssA::spc ywjE::cat transduction → HB5461 
HB5473 NCIB3610 ywnE::cat mprF::kan transduction → HB5464 
HB5474 NCIB3610 mprF::kan ywjE::cat transduction → HB5463 
HB5475 NCIB3610 ugtP::MLS mprF::kan pssA::spc transduction → HB5467 
HB5476 NCIB3610 ugtP::MLS pssA::spc ywnE::cat transduction → HB5466 
HB5477 NCIB3610 ugtP::MLS mprF::kan ywnE::cat transduction → HB5467 
HB5478 NCIB3610 mprF::kan pssA::spc  ywnE::cat transduction → HB5470 
HB5479 NCIB3610 ugtP::MLS mprF::kan pssA::spc ywnE::cat transduction → HB5475 
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Table 4.1 (Continued) 
* Capped letters indicate sequences complementary to antibiotic resistance genes. 
Underlined sequences indicate restriction sit 
 
 
 
 
 
Oligonucleotide primers 
# Name Sequence* 
1761 yfiW up fwd tccaagcgcctgaatcagcc 
1762 yfiW up rev (kan) CCTATCACCTCAAATGGTTCGCTGtgatgaccatgagcgtacg 
1763 yfiX do fwd (kan) CGAGCGCCTACGAGGAATTTGTATCGccatgttcctcgttacacg 
1764 yfiX  do rev   gagccgtaaagtcatggaagg 
1913 psd up fwd ccgatccttctggcaatcgg 
1914 psd  up rev (MLS) GAGGGTTGCCAGAGTTAAAGGATCgacagacgatgattcgtcagc 
1915 psd do fwd (MLS) CGATTATGTCTTTTGCGCAGTCGGCcaagtcggagaactgatagg 
1916 psd  do rev   gacatcttctgtgtgccatacagcg 
2092 ugtP up fwd gacgagctatactacgtgcc 
2093 ugtP  up rev (MLS) GAGGGTTGCCAGAGTTAAAGGATCttggctacctgcacatgtcc 
2094 ugtP do fwd (MLS) CGATTATGTCTTTTGCGCAGTCGGCggaatcagaaatgatgaccg 
2095 ugtP  do rev   tgccgcttatccgtaaagcc 
2100 ywnE up fwd gctcttcctttatttgtcgtgcg 
2101 ywnE up rev (tet) GAGAACAACCTGCACCATTGCAAGAccaagatgcactggcatcgc 
2102 ywnE do fwd (tet) GGGATCAACTTTGGGAGAGAGTTCctatgaggagtatctgcagc 
2103 ywnE  do rev   tttgtacagtgacgcagacc 
2367 ywnE up rev (cat) CTTGATAATAAGGGTAACTATTGCCccaagatgcactggcatcgc 
2368 ywnE do fwd (cat) GGGTAACTAGCCTCGCCGGTCCACGctatgaggagtatctgcagc 
2104 ywjE up fwd agaaagcccatgctcatgcc 
2105 ywjE up rev (kan) CCTATCACCTCAAATGGTTCGCTGgatatcaagcagaatcaaggc 
2106 ywjE do fwd (kan) CGAGCGCCTACGAGGAATTTGTATCGtggaggatttcagcaagcg 
2107 ywjE  do rev   Agacaaacggaacatcctcc 
3880 ywjE up rev (cat) CTTGATAATAAGGGTAACTATTGCCgatatcaagcagaatcaaggc 
3881 ywjE do fwd (cat) GGGTAACTAGCCTCGCCGGTCCACGtggaggatttcagcaagcg 
2369 pssA up fwd cttgagacggcacatctggc 
2370 pssA up rev (spc) CGTTACGTTATTAGCGAGCCAGTCcctatcgtaatcatacaggg 
2371 pssA do fwd (spc) CAATAAACCCTTGCCCTCGCTACGcagaaaacctggagtctggg 
2372 pssA  do rev   gaaccacaccgtcaacaggg 
2449 pssA up rev (spc xylA) CAATAAACCCTTGCCCTCGCTACGcctatcgtaatcatacaggg 
2450 pssA do fwd (spc xylA SD) CCAACCAGATAAGTGCGAGCCAGTCAAGAGGATCTGCatggaattagttcagcagc 
2451 ybfM up rev (spc xylA) CAATAAACCCTTGCCCTCGCTACGcgtaatccgctatgagctgc 
2452 ybfM do fwd (spc xylA SD) CCAACCAGATAAGTGCGAGCCAGTCAAGAGGATCTGCatgtttaatacggctgtaaag 
2866 PsigM fwd (H) ccgtaagctttgggtactatatagtaatggtg 
436 SigM-r3 cgggatcccagtaagtcttcagcaagatg 
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4. Results and Discussion 
The Bacillus subtilis cytoplasmic membrane can be dramatically simplified.  
Bacterial cytoplasmic membranes display a great variety of lipid compositions. PhE is 
a dominant inner membrane component in E. coli (75% of total; (12)), whereas in 
Staphylococcus aureus membranes are predominantly formed from PhG (~90% of 
total; (39)). In Mycobacterium tuberculosis, membranes are dominated by 
phosphatidylinositol mannosides (~70%; (50) ). In many other cases, no single lipid 
type dominates and in all systems there are at least three or more different types of 
lipid headgroup represented. These observations are consistent with the hypothesis 
that membrane function requires lipid components with different physio-chemical 
properties.  
 Here, I set out to characterize a set of strains with altered membrane 
composition using B. subtilis as a model system. I inactivated genes involved in the 
biosynthesis of complex lipids including genes necessary for the synthesis of PhE 
(pssA; P), GL (ugtP; U), LPG (mprF; M), and CL (ywnE; Y) by allelic replacement 
with antibiotic resistance cassettes (Table 4.1). I also constructed mutants of psd (S) 
and ywjE (J). The psd mutant accumulates phosphatidylserine (PS), but is unable to 
synthesize PhE. The ywjE mutant is missing a minor CLS thought to be present during 
sporulation (25). Allelic replacements were verified by PCR, and the absence PhE and 
LPG of was verified by thin-layer-chromatography (TLC) (Fig. 4.1 and data not 
shown). By additional rounds of transformation I created a suite of mutants comprised 
of various combinations of these mutations with increasingly simplified membrane 
composition. Surprisingly I was able to create a viable quadruple mutant strain (Q;  
ugtP pssA  mprF ywnE) with membranes containing predominantly, if not exclusively, 
phosphatidylglycerol (PhG) (Table 4.1). The only other DAG-based lipids that might 
be present are PA and DAG itself. Previously, DAG was reported to be 
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Figure 4.1. TLC analysis of membrane mutants. Membrane lipids were extracted from 
exponential cultures of WT or membrane mutants grown in LB using a modified 
Bligh-Dyer method (5). Extracted lipids were spotted to silica TLC plate and detected 
with molybdenum blue (Sigma) and compared to standards as indicated. 
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present in low levels in B. subtilis membranes (4). DAG is formed as a precursor to 
GL and is also generated as an intermediate during the synthesis of lipoteichoic acids 
(23).  
I monitored growth rates for each of our strains using a BioScreen automated 
growth curve (optical density) analysis system. All mutant strains were able to grow in 
a variety of liquid and solid media including LB, LB + 2% glucose, Difco Sporulation 
Medium (DSM), minimal competence medium (MC), as well as a defined minimal 
medium (MM). However, some of the strains had increased doubling and/or lag times. 
In LB medium, increased doubling times were observed for those strains lacking the 
neutral lipid GL (ugtP mutant; U; Table 4.2). Comparison of the U single and double 
mutants lacking GL indicates that the loss of UgtP is primarily responsible for the 
growth defects in LB (Table 4.2). Surprisingly, the quadruple mutant (UPMY) 
exhibits a doubling time similar to that of the double mutants. However the lag time of 
this strain, as well as all strains lacking ugtP, is considerably longer than that of WT 
(data not shown). It is important to note, however, that UgtP plays several roles in the 
cell. In addition to the synthesis of GL, UgtP is involved in generating anchor lipids 
for lipoteichoic acids (24), and functions as a sensor to couple cell division to the 
availability of nutrients (60).  
In minimal medium, in which cells grow considerably slower, the only strain 
to demonstrate a significantly increased doubling time was the UPMY quadruple 
mutant (74 vs. 48 min for WT). Growth rates in DSM were similar to those in LB 
(data not shown). All strains were capable of sporulating: phase bright spores were 
observed after growth in DSM for 24 hours and all strains formed pigmented colonies 
when streaked on DSM plates.  
The viability and robust growth of strains with greatly simplified membrane 
composition is surprising in light of previous studies of E. coli mutants. For example, 
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     Table 4.2. Effects of membrane headgroup alteration on cell growth 
 
Straina Membrane lipid  (charge) Doubling timeb 
 
PhG 
-1 
CL 
-2 
PhE 
0 
GL 
0 
LPG 
+1 
LB MM 
WT 
     34 ± 1 48 ± 3 
P*      37 ± 2 49 ± 3 
U      50 ± 3 51 ± 4 
M*      38 ± 3 45 ± 2 
Y      36 ± 4 50 ± 1 
S      37 ± 2 52 ±2 
J      38 ± 0 49 ± 2 
UP      37 ± 5 50 ± 3 
UM      44 ± 7 62 ± 8 
UY      47 ± 8 51 ± 2 
UJ      40 ± 2 51 ± 2 
PM      40 ± 4 44 ± 5 
PY*      41± 5 50 ± 2 
PJ      39 ± 1 55 ± 2 
MY*      40 ± 4 50 ± 3 
MS      38± 2 47 ± 2 
YJ      41 ± 1 49 ± 2 
YS      39 ± 3 52 ± 4 
UPM      37 ± 2 55 ± 6 
UPY      53 ± 9 50 ± 4 
UMY      42 ± 9 49 ± 5 
MPY (T)      37 ± 3 46 ± 7 
UPMY (Q)      40 ±7 74 ± 9 
 
LB: Luria-Bertani medium, MM: defined minimal medium. 
* Lipid composition verified by TLC. 
a P : pssA::spc, U : ugtP::MLS, M : mprF::kan, Y : ywnE::cat, S : psd::MLS, J : 
ywjE::kan 
White boxes: lipid is present in the membrane, black boxes: lipid is absent, grey 
boxes: CL may be partially lacking, at least under some growth conditions, due to loss 
of the minor CLS encoded by ywjE. 
b Doubling time calculated for maximum specific growth rate. 
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an E. coli pssA null mutant has severe growth defects and requires divalent metal ion 
supplementation for growth (14), and a mutant lacking both PhE and CL is non viable 
(41). These defects are thought to result from a requirement for the formation of non-
bilayer structures within the membrane (facilitated by PhE) as well as the proper 
localization of membrane proteins (2, 35). These differences may result, in part, from 
the fact that B. subtilis only contains a single membrane whereas E. coli requires both 
an inner and outer membrane.   
mprF and ugtP mutants exhibit increased sensitivity to cationic antimicrobial 
peptides. Modification of the membrane has been proposed as a strategy for 
protection against cationic antimicrobial peptides (56). I tested my collection of strains 
for their sensitivity to a variety of cell envelope active compounds including 
vancomycin, nisin, sublancin, and duramycin. In the presence of the glycopeptide 
antibiotic vancomycin most strains grew to an OD600 comparable to that of WT. 
However, all ugtP mutant strains were vancomycin sensitive (data not shown). 
Conversely, in the presence of the cationic lantibiotic nisin mprF mutants were 
sensitive (Fig. 4.2A). LPG can constitute up to 20% of the B. subtilis membrane (15), 
and has been shown to impart resistance to cationic antimicrobials including nisin, 
vancomycin and human defensins in S. aureus (49, 56). 
Next I tested sensitivity to the bacteriocin sublancin produced by B. subtilis 
strains harboring the SPβ prophage. my mutant strains were constructed in B. subtilis 
CU1065 which lacks the SPβ prophage, and is therefore sublancin sensitive. To test 
sublancin senstivity, lawns were spotted with B. subtilis JH642 (a sublancin producer) 
or an isogenic strain unable to produce sublancin (sunA::kan mutant). Increased zones 
of inhibition were observed for all ugtP mutants spotted with JH642 but not with the 
sunA mutant (Fig. 4.2B). Sensitivity was not further increased in the double, triple or 
quadruple ugtP lacking mutants.  
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Figure 4.2. Variation of cytoplasmic membrane composition results in altered 
antibiotic sensitivity. (A) Deletion of mprF leads to increased sensitivity to nisin. WT 
(black symbols) and mprF::kan cells (grey symbols) were grown in LB to early log 
and then either left untreated (squares) or treated with 10 μg/ml nisin (triangles).  
(B) Strains lacking ugtP demonstrate increased sensitivity to sublancin. Lawns of 
various strains spotted with the sublancin producing B. subtilis JH642 (left spot), or a 
JH642 strain containing a sunA deletion. 
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Duramycin is a lanthionine containing antimicrobial peptide (or lantibiotic) 
produced by Streptoverticillium cinnamoneum. Previous studies have reported that 
strains selected for increased resistance to duramycin demonstrated decreased levels of 
PhE and increased levels of CL (16), and have predicted a mode of action in which 
duramycin binds to PhE and then inserts into the membrane creating pores (22). 
Consistent with this expectation, pssA and psd mutant strains exhibited greatly 
increased resistance to duramycin relative to the WT strain (data not shown). No other 
single mutation conferred this resistance, and double and triple mutants lacking either 
pssA or psd showed similar resistance levels to that of the single mutants. 
Unexpectedly, the UPMY quadruple mutant was more sensitive to duramycin than 
other PhE-lacking mutants, but still more resistant than WT. This suggests that the 
requirement for PhE in the biological action of duramycin may be bypassed in strains 
with grossly perturbed membrane structure.  
In B. subtilis, the PhE biosynthetic genes (pssA, psd) are part of a tri-cistronic 
operon pssA ybfM psd. In order to study the possible role of ybfM in PhE biosynthesis 
and duramycin sensitivity, I constructed a strain in which ybfM was replaced by a 
spectinomycin resistance cassette, and psd was placed under the control of a xylose 
inducible promoter (ybfM::spc-PxylA). In the presence of xylose strain ybfM::spc-PxylA 
was as sensitive to duramycin as WT, whereas in the presence of glucose it was as 
resistant as a pssA null mutant (data not shown). This suggests that ybfM is not 
required for the synthesis or localization of PhE. In other organisms containing 
homologs of these proteins, the tricistronic operon structure is not conserved, and 
often pssA and psd are even situated in separate operons. 
Cells containing simplified cytoplasmic membranes exhibit aberrant 
morphologies. Microscopic observation indicates that mutants with altered membrane 
composition have distinctive changes in cell morphology. During mid-exponential 
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growth in LB, the ugtP mutant was the only single mutant to demonstrate a change in 
cell shape: cells were shorter and tended to curl at the ends (Fig. 4.3). Double mutants 
lacking ugtP appeared mostly as curling short chains of cells or clumps of curled cells 
while triple mutants demonstrated lengthened filaments of curled cells (data not 
shown). The most dramatic effect is observed in the quadruple mutant in which the 
filamentation and curling is even more pronounced (Fig. 4.3). Double mutants that still 
contain ugtP resembled WT cells, with a small amount of cells in longer chains (data 
not shown), while the MPY triple mutant did not curl but was highly filamentous (Fig. 
4.3). At later growth stages in LB the filamentation phenotype is lost and cells appear 
as either single cells or short chains (data not shown). When the MPY and UPMY 
mutants were grown in LB supplemented with Mg2+, known to stabilize the effects of 
PhE loss in E.coli (12), the filamentation was reduced. Staining of these filamentous 
cells with the non-specific membrane stain FM 4-64 and fluorescently-labeled 
vancomycin (which targets uncrosslinked peptidoglycan containing pentapeptide 
sidechains) clearly demonstrates that these are septated filaments (Fig. 4.3). 
Fluorescently-labeled vancomycin stains the septal regions and also in a characteristic 
helical pattern along the axis of the cell as also seen for WT cells (58) (Fig. 4.3 and 
data not shown), suggesting that peptidoglycan synthesis and incorporation remains 
mostly unimpaired even in the quadruple mutant. Staining with FM 4-64 showed a 
similar accumulation at the septal region, with no obvious aberrant membrane 
formations such as involutions or blebs.  
In general, the most dramatic morphological changes were observed in those 
cells lacking GL. ugtP codes for a multifunctional UDP-glucose:diacylglycerol 
glucosyltransferase that is required for the (i) formation of GL (24, 47), (ii) synthesis 
of diglucosyldiacylglycerol, the membrane anchor for lipotechoic acids (24, 29), and  
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Figure 4.3. Alteration of cytoplasmic membrane leads to aberrant morphology. 
Exponential phase cultures grown in LB were treated with both the non-specific 
membrane dye FM 4-64 and fluorescently-labeled vancomycin. 
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(iii) coupling nutrient availability to cell division in B.subtilis (60). When nutrients are 
available, UgtP is expressed at high levels, evenly distributed in the cytoplasm and 
concentrated at the septum, co-localizing and interacting with FtsZ (60). UgtP is 
proposed to inhibit the assembly of FtsZ rings by sequestering the FtsZ subunits, 
resulting in larger cells at the time of division (54,60). Upon carbon depletion 
localization of UgtP to the septum is abolished resulting in smaller cells. This dual role 
of UgtP in envelope biosynthesis and regulation of cell size could explain the severity 
of the defects seen in ugtP null mutants. 
Cells containing simplified cytoplasmic membranes are altered for swarming 
motility. In order to study the effect of alteration of cytoplasmic membrane 
composition on motility and biofilm formation I transferred my mutant collection into 
a NCIB 3610 background which, unlike most B. subtilis 168 laboratory strains, 
exhibits a robust swarming phenotype. In this background, the ugtP mutant strains 
exhibited decreased swarming while, curiously, some of the single mutants displayed 
enhanced swarming (Fig. 4.4). This enhanced swarming is reduced only in the PY and 
MY double mutants as well as the MPY triple mutant. This does not seem to be due to 
a specific lack of CL since the Y single mutant did not show a similar decrease. 
Surprisingly, all strains tested were able to form characteristic pellicules on the air-
liquid interface of MSgg medium. However, the biofilms of strains lacking ugtP were 
somewhat flatter and more matte, while that of the MPY triple mutant resembled WT 
(data not shown). 
Transcriptome comparisons.  I conducted DNA microarray experiments to compare 
the transcriptional profile of the ugtP single mutant, MPY triple mutant, and UMPY 
quadruple to that of WT cells in LB medium at mid-log stage. These mutations are 
highly pleiotropic and we identified a large number of genes that were reproducibly 
altered in expression levels relative to WT. These included genes 
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Figure 4.4. Deletion of ugtP results in a swarming defect. Membrane mutants in the 
NCIB3610 background were grown to mid exponential phase in LB and then spotted 
to 0.7% LB-agar plates. Plates were incubated overnight. 
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involved in carbon and protein metabolism, cell wall and membrane biosynthesis, 
DNA metabolism and repair, motility and chemotaxis, and production of secondary 
metabolites, as well as a large number of uncharacterized membrane proteins. In 
addition, the expression of many known or putative ABC transporter and other 
transport permeases were affected, including multidrug-efflux pumps and antibiotic 
resistance proteins. Alterations of membrane composition also affected the level of 
expression of numerous known and predicted transcriptional regulators. In general, 
these changes were most dramatic for the ugtP mutant and the UMPY quadruple 
mutant, with generally more modest changes noted in the MPY triple mutant.  These 
results suggest that cell envelope perturbations caused by the absence of UgtP are 
potentially the most deleterious to the cell and result in a shift in the transcriptional 
profile. 
To determine the likely origins of these large shifts in transcriptional pattern, I 
have linked many of the genes affected (either positively or negatively) by membrane 
alteration to known regulons. As summarized in Fig. 4.5, large fractions of several 
known regulons were altered in their expression in one or more of the tested mutant 
backgrounds. For example, genes regulated by σD (involved in motility, chemotaxis, 
and autolysin synthesis; 32) were expressed at lower levels in all three mutant 
backgrounds. In contrast, numerous members of the large DegU and σB (general stress 
response) regulons were elevated in expression in these strains.  There was also a 
general increase in the expression of genes under the control of the sporulation 
specific sigma factors σE, σF, σG and σK in all backgrounds (Fig. 4.5). This suggests 
that sporulation may have initiated earlier and asynchronously within this growing 
population whereas sporulation genes are generally not expressed during logarithmic 
growth in WT.    
 115
 
 
 
 
 
 
Figure 4.5. Analysis of regulons demonstrating differential expression patterns. 
Microarray experiments comparing WT with either ugtP, MPY or UMPY mutants 
strains. RNA extracted from mid-log cells grown in LB. Results represent average of 
three separate experiments. Each three bars correspond to a specific regulon, the order 
of experiments is WT vs. ugtP, WT vs. MPY, WT vs. UPMY. The height of the bar 
represents the overall percentage of the regulon with altered expression.  
Grey sections represents % of regulon that was downregulated at least 1.5 fold, white 
sections represents % of regulon that was upregulated at least 1.5 fold The number of 
genes in each regulon is beneath the regulon name (adapted from 44, 3, 51, 1, 46, 53, 
57, 18, 19, 17, 11, 38, 26 and  52). 
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In several cases, the role of UgtP appeared to be most important since the 
transcriptome changes were most dramatic for the U and UMPY mutations with 
relatively little effect noted in the MPY triple mutant. For example, genes involved in 
biosynthesis of fatty acids and under the negative control of FapR were strongly 
downregulated in both the U and UMPY backgrounds but only slightly altered in the 
MPY triple mutant. Genes negatively regulated by SinR, involved in the production of 
exopolysaccharides and biofilm formation (11), were also downregulated only in a U 
and UMPY background. In addition, the σM cell envelope stress regulon (17) was 
induced only in the U and UMPY backgrounds. This induction was verified by β-
galactosidase assays showing that in a ugtP null background the expression level of 
the PsigM promoter was higher throughout all growth phases (Fig. 4.6A), although it 
could still be additionally induced by treatment with vancomycin (Fig. 4.6B). 
Interestingly, the expression of the regulons of ECF sigma factors σW (which provides 
intrinsic resistance to antimicrobial compounds; 9) and σX (which regulates 
modification of the cell envelope and resistance to cationic antimicrobial peptides (10)  
were unaltered.  
A contrasting example is provided by analysis of genes assigned to the 
YvrGHb TCS regulon. YvrGHb is reported to regulate cell surface homeostatic 
functions (52). This regulon was expressed at a reduced level in the MPY triple mutant 
but affected to a lesser extent in the quadruple mutant.  
Among the most highly induced genes in the UMPY and MPY mutant 
backgrounds were the yrkNM operon encoding for a GCN5-related N-acetyltransferase 
and an unknown protein respectively, and yrkO which encodes for a putative 
transporter. yrkN and yrkO are thought to be positively regulated by the divergently 
encoded response regulator YrkP, which was suggested to regulate membrane function  
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Figure 4.6. Activity of the σM promoter is increased in a ugtP::MLS background.  
(A) WT (black symbols) and ugtP::MLS (grey symbols) cells containing a PsigM-lacZ 
promoter fusion were grown in LB. Samples were taken periodically and OD600 
(squares) and LacZ activity (triangles) were monitored. (B) PsigM can still be induced 
in a ugtP::MLS background. Mid-log cells either untreated (black) or treated with 2 
μg/ml vancomycin for 30 min. 
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(43). However, the expression of the ykcBC operon, also thought to be regulated by 
YrkP (43), remained unchanged in all three backgrounds tested. 
Concluding remarks. We report the construction of a large set of isogenic strains 
with alterations in membrane lipid composition. Perhaps the most surprising finding 
from this work is that the membrane of B. subtilis can be greatly simplified by 
removal of GL, PhE, LPG, and CL and the cells grow robustly. These cells are 
morphologically abnormal and exhibit a combination of cell separation and cell shape 
defects: they grow as long and curled filaments. In this initial survey, we have 
highlighted the effects of grossly perturbing membrane composition on antibiotic 
sensitivity, swarming motility, and global transcription patterns. In many of our 
phenotypic assays, the loss of ugtP appears to have a dominant effect, with changes in 
the ugtP single mutant often more dramatic than in the MPY triple mutant. Additional 
studies are clearly required to further understand these complex phenotypes, and to 
determine if the ugtP phenotypes are due to the loss of GL or in addition or instead to 
the important role of this protein as a metabolic sensor.  
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